1
|
Motosugi N, Sugiyama A, Okada C, Otomo A, Umezawa A, Akutsu H, Hadano S, Fukuda A. De-erosion of X chromosome dosage compensation by the editing of XIST regulatory regions restores the differentiation potential in hPSCs. Cell Rep Methods 2022; 2:100352. [PMID: 36590687 PMCID: PMC9795333 DOI: 10.1016/j.crmeth.2022.100352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Revised: 06/29/2022] [Accepted: 10/28/2022] [Indexed: 12/02/2022]
Abstract
Human pluripotent stem cells (hPSCs) regularly and irreversibly show the erosion of X chromosome inactivation (XCI) by long non-coding RNA (lncRNA) XIST silencing, causing challenges in various applications of female hPSCs. Here, we report reliable methods to reactivate XIST with monoallelic expression in female hPSCs. Surprisingly, we find that the editing of XIST regulatory regions by Cas9-mediated non-homologous end joining is sufficient for the reactivation of XIST by endogenous systems. Proliferated hPSCs with XIST reactivation show XCI from an eroded X chromosome, suggesting that hPSCs with normal dosage compensation might lead to a growth advantage. Furthermore, the use of targeting vectors, including the XIST regulatory region sequences and selection cassette, enables XIST reactivation in hPSCs with high efficiency. XIST-reactivated hPSCs can show the restoration of differentiation potential. Thus, our findings demonstrate that XIST re-expression is a beneficial method to maximize the use of female hPSCs in various applications, such as proper disease modeling.
Collapse
Affiliation(s)
- Nami Motosugi
- Department of Molecular Life Sciences, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Akiko Sugiyama
- Department of Molecular Life Sciences, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Asako Otomo
- Department of Molecular Life Sciences, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
- The Institute of Medical Sciences, Tokai University, Isehara, Kanagawa, Japan
- Micro/Nano Technology Center, Tokai University, Hiratsuka, Kanagawa, Japan
| | - Akihiro Umezawa
- Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan
| | - Hidenori Akutsu
- Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan
| | - Shinji Hadano
- Department of Molecular Life Sciences, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
- The Institute of Medical Sciences, Tokai University, Isehara, Kanagawa, Japan
- Micro/Nano Technology Center, Tokai University, Hiratsuka, Kanagawa, Japan
| | - Atsushi Fukuda
- Department of Molecular Life Sciences, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
- The Institute of Medical Sciences, Tokai University, Isehara, Kanagawa, Japan
- Micro/Nano Technology Center, Tokai University, Hiratsuka, Kanagawa, Japan
- Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan
| |
Collapse
|
2
|
Okada C, Kaps M, Walter I, Gautier C, Aurich J, Aurich C. 84 Low plasma progestogen concentration during the early luteal phase delays endometrial development and the beginning of placentation in mares. Reprod Fertil Dev 2022. [DOI: 10.1071/rdv35n2ab84] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
|
3
|
Fukuda A, Hazelbaker DZ, Motosugi N, Hao J, Limone F, Beccard A, Mazzucato P, Messana A, Okada C, San Juan IG, Qian M, Umezawa A, Akutsu H, Barrett LE, Eggan K. De novo DNA methyltransferases DNMT3A and DNMT3B are essential for XIST silencing for erosion of dosage compensation in pluripotent stem cells. Stem Cell Reports 2021; 16:2138-2148. [PMID: 34416176 PMCID: PMC8452533 DOI: 10.1016/j.stemcr.2021.07.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2021] [Revised: 07/21/2021] [Accepted: 07/21/2021] [Indexed: 12/31/2022] Open
Abstract
Human pluripotent stem cells (hPSCs) have proven to be valuable tools for both drug discovery and the development of cell-based therapies. However, the long non-coding RNA XIST, which is essential for the establishment and maintenance of X chromosome inactivation, is repressed during culture, thereby causing erosion of dosage compensation in female hPSCs. Here, we report that the de novo DNA methyltransferases DNMT3A/3B are necessary for XIST repression in female hPSCs. We found that the deletion of both genes, but not the individual genes, inhibited XIST silencing, maintained the heterochromatin mark of H3K27me3, and did not cause global overdosage in X-linked genes. Meanwhile, DNMT3A/3B deletion after XIST repression failed to restore X chromosome inactivation. Our findings revealed that de novo DNA methyltransferases are primary factors responsible for initiating erosion of dosage compensation in female hPSCs, and XIST silencing is stably maintained in a de novo DNA-methylation-independent manner.
Collapse
Affiliation(s)
- Atsushi Fukuda
- The Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan; The Institute of Medical Science, Tokai University, Kanagawa, Japan; Micro/Nano Technology Center, Tokai University, Hiratsuka, Kanagawa, Japan; Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan.
| | - Dane Z Hazelbaker
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Nami Motosugi
- Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Jin Hao
- The Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Francesco Limone
- The Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Amanda Beccard
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Patrizia Mazzucato
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Angelica Messana
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Irune Guerra San Juan
- The Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Menglu Qian
- The Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Akihiro Umezawa
- Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan
| | - Hidenori Akutsu
- Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan
| | - Lindy E Barrett
- The Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Kevin Eggan
- The Harvard Stem Cell Institute and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
| |
Collapse
|
4
|
Motosugi N, Okada C, Sugiyama A, Kawasaki T, Kimura M, Shiina T, Umezawa A, Akutsu H, Fukuda A. Deletion of lncRNA XACT does not change expression dosage of X-linked genes, but affects differentiation potential in hPSCs. Cell Rep 2021; 35:109222. [PMID: 34107248 DOI: 10.1016/j.celrep.2021.109222] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Revised: 01/08/2021] [Accepted: 05/14/2021] [Indexed: 12/28/2022] Open
Abstract
Female human pluripotent stem cells (hPSCs) regularly show erosion of X chromosome inactivation featured by the loss of the long non-coding (lnc) RNA XIST and the accumulation of lncXACT. Here, we report that a common mechanism for the initiation of erosion depends on XIST loss but not XACT accumulation on inactive X chromosomes. We further demonstrate that XACT deletion does not affect X-linked gene dosage in eroded hPSCs and that aberrant XIST RNA diffusion induced by the CRISPR activation system is independent of the presence of XACT RNA. In contrast, the deletion of XACT results in the upregulation of neuron-related genes, facilitating neural differentiation in both male and eroded female hPSCs. XACT RNA repression by CRIPSR inhibition results in the same phenotype. Our study finds that XACT is dispensable for maintaining the erosion of X-lined gene repression on inactive X chromosomes but affects neural differentiation in hPSCs.
Collapse
Affiliation(s)
- Nami Motosugi
- Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Akiko Sugiyama
- Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Tomoyuki Kawasaki
- Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan
| | - Minoru Kimura
- The Institute of Medical Sciences, Tokai University, Isehara, Japan
| | - Takashi Shiina
- Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Akihiro Umezawa
- Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan
| | - Hidenori Akutsu
- Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan
| | - Atsushi Fukuda
- Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan; The Institute of Medical Sciences, Tokai University, Isehara, Japan; Micro/Nano Technology Center, Tokai University, Hiratsuka, Kanagawa, Japan; Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan.
| |
Collapse
|
5
|
Owada S, Endo H, Okada C, Yoshida K, Shida Y, Tatemichi M. Setanaxib as a Potent Hypoxia-specific Therapeutic Agent Against Liver Cancer. Anticancer Res 2020; 40:5071-5079. [PMID: 32878795 DOI: 10.21873/anticanres.14510] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2020] [Revised: 06/30/2020] [Accepted: 07/01/2020] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM Liver cancer has extremely poor prognosis. The cancerous tissues contain hypoxic regions, and the available drugs are poorly effective in hypoxic environments. NADPH oxidase 4 (NOX4), producing reactive oxygen species (ROS), may contribute to cancer malignancy under hypoxic conditions. However, its role in liver cancer has not been examined in detail. Our aim was to explore the effects of setanaxib, a recently developed selective NOX4 inhibitor, in liver cancer cells under hypoxic conditions. MATERIALS AND METHODS Liver cancer cell lines (HepG2, HLE and Alexander) were treated with hypoxia-mimetic agent cobalt chloride. Cytotoxicity assays, immunoblot analysis and ROS detection assay were performed to detect the effect of setanaxib under hypoxic conditions. RESULTS Setanaxib exhibited hypoxia-selective cytotoxicity and triggered apoptosis in cancer cells. Moreover, setanaxib caused mitochondrial ROS accumulation under hypoxic conditions. Treatment with antioxidants markedly attenuated setanaxib-induced cytotoxicity and apoptosis under hypoxic conditions. CONCLUSION Setanaxib caused mitochondrial ROS accumulation in a hypoxia-selective manner and evoked cancer cell cytotoxicity by inducing apoptosis. Thus, setanaxib has a great potential as a novel anticancer compound under hypoxic conditions.
Collapse
Affiliation(s)
- Satoshi Owada
- Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan
| | - Hitoshi Endo
- Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University, Isehara, Japan
| | - Kazuhiro Yoshida
- Support Center for Medical Research and Education, Tokai University, Isehara, Japan
| | - Yukari Shida
- Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan
| | - Masayuki Tatemichi
- Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan
| |
Collapse
|
6
|
Nagata E, Fujii N, Kohara S, Okada C, Satoh T, Takekoshi S, Takao M, Mihara B, Takizawa S. Inositol hexakisphosphate kinase 2 promotes cell death of anterior horn cells in the spinal cord of patients with amyotrophic lateral sclerosis. Mol Biol Rep 2020; 47:6479-6485. [PMID: 32929655 DOI: 10.1007/s11033-020-05688-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2020] [Accepted: 07/26/2020] [Indexed: 11/25/2022]
Abstract
We have previously reported that inositol hexakisphosphate kinase (InsP6K)2 mediates cell death. InsP6K2 is abundantly expressed in anterior horn cells of the mammalian spinal cord. We investigated the role of InsP6K2 in spinal cords of patients with amyotrophic lateral sclerosis (ALS). Autopsy specimens of lumbar spinal cords from ten patients with sporadic ALS and five non-neurological disease patients (NNDPs) were obtained. We performed quantitative real-time PCR, immunostaining, and western blotting for InsP6K1, InsP6K2, InsP6K3, protein kinase B (Akt), casein kinase 2 (CK2), and 90-kDa heat-shock protein (HSP90). In contrast to InsP6K1 and InsP6K3 mRNA expression, InsP6K2 levels in anterior horn cells of the spinal cord were significantly increased in ALS patients compared to NNDPs. In ALS patients, InsP6K2 translocated from the nucleus to the cytoplasm. However, we observed a decrease in HSP90, CK2, and Akt activity in ALS patients compared to NNDPs. A previous study reported that InsP6K2 activity is suppressed after binding to HSP90 and subsequent phosphorylation and degradation by CK2, thus decreasing InsP6K2 activity. However, InsP7, which is generated by InsP6K2, can compete with Akt for PH domain binding. Consequently, InsP7 can inhibit Akt phosphorylation. Our results suggest that InsP6K2 is activated in the spinal cord of patients with ALS and may play an important role in ALS by inducing cell death mechanisms via Akt, CK2, and HSP90 pathways.
Collapse
Affiliation(s)
- Eiichiro Nagata
- Department of Neurology, Tokai University School of Medicine, 143 Shimo-Kasuya, Isehara, Kanagawa, 259-1193, Japan.
| | - Natsuko Fujii
- Department of Neurology, Tokai University School of Medicine, 143 Shimo-Kasuya, Isehara, Kanagawa, 259-1193, Japan
| | - Saori Kohara
- Department of Neurology, Tokai University School of Medicine, 143 Shimo-Kasuya, Isehara, Kanagawa, 259-1193, Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University, Isehara, Japan
| | - Tadayuki Satoh
- Support Center for Medical Research and Education, Tokai University, Isehara, Japan
| | - Susumu Takekoshi
- Department of Clinical Pathology, Tokai University School of Medicine, Isehara, Japan
| | - Masaki Takao
- Department of Clinical Laboratory, National Center of Neurology and Psychiatry (NCNP), National Center Hospital, Tokyo, Japan
| | - Ban Mihara
- Department of Neurology, Mihara Memorial Hospital, Gunma, Japan
| | - Shunya Takizawa
- Department of Neurology, Tokai University School of Medicine, 143 Shimo-Kasuya, Isehara, Kanagawa, 259-1193, Japan
| |
Collapse
|
7
|
Watanabe N, Kidokoro M, Tanaka M, Inoue S, Tsuji T, Akatuska H, Okada C, Iida Y, Okada Y, Suzuki Y, Sato T, Yahata T, Hirayama N, Nakagawa Y, Inokuchi S. Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells. Cancer Cell Int 2020; 20:263. [PMID: 32581653 PMCID: PMC7310449 DOI: 10.1186/s12935-020-01328-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Accepted: 06/07/2020] [Indexed: 01/08/2023] Open
Abstract
Background The transmembrane glycoprotein podoplanin (PDPN) is upregulated in some tumors and has gained attention as a malignant tumor biomarker. PDPN molecules have platelet aggregation-stimulating domains and, are therefore, suggested to play a role in tumor-induced platelet activation, which in turn triggers epithelial-to-mesenchymal transition (EMT) and enhances the invasive and metastatic activities of tumor cells. In addition, as forced PDPN expression itself can alter the propensity of certain tumor cells in favor of EMT and enhance their invasive ability, it is also considered to be involved in the cell signaling system. Nevertheless, underlying mechanisms of PDPN in tumor cell invasive ability as well as EMT induction, especially by platelets, are still not fully understood. Methods Subclonal TE11A cells were isolated from the human esophageal squamous carcinoma cell line TE11 and the effects of anti-PDPN neutralizing antibody as well as PDPN gene knockout on platelet-induced EMT-related gene expression were measured. Also, the effects of PDPN deficiency on cellular invasive ability and motility were assessed. Results PDPN-null cells were able to provoke platelet aggregation, suggesting that PDPN contribution to platelet activation in these cells is marginal. Nevertheless, expression of platelet-induced EMT-related genes, including vimentin, was impaired by PDPN-neutralizing antibody as well as PDPN deficiency, while their effects on TGF-β-induced gene expression were marginal. Unexpectedly, PDPN gene ablation, at least in either allele, engendered spontaneous N-cadherin upregulation and claudin-1 downregulation. Despite these seemingly EMT-like alterations, PDPN deficiency impaired cellular motility and invasive ability even after TGF-β-induced EMT induction. Conclusions These results suggested that, while PDPN seems to function in favor of maintaining the epithelial state of this cell line, it is indispensable for platelet-mediated induction of particular mesenchymal marker genes as well as the potentiation of motility and invasion capacity.
Collapse
Affiliation(s)
- Nobuo Watanabe
- Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Masako Kidokoro
- Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Makiko Tanaka
- Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Shigeaki Inoue
- Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Tomoatsu Tsuji
- Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Hisako Akatuska
- Department of Host Defense Mechanism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Yumi Iida
- Support Center for Medical Research and Education, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Yoshinori Okada
- Support Center for Medical Research and Education, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Yusuke Suzuki
- Support Center for Medical Research and Education, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Takehito Sato
- Department of Host Defense Mechanism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Takashi Yahata
- Research Center for Regenerative Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Noriaki Hirayama
- Institute of Advanced Biosciences, Tokai University, 411 Kitakaname, Hiratsuka, Kanagawa 259-1292 Japan
| | - Yoshihide Nakagawa
- Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| | - Sadaki Inokuchi
- Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan
| |
Collapse
|
8
|
Hayashi H, Wang T, Tanaka M, Ogiwara S, Okada C, Ito M, Fukunishi N, Iida Y, Nakamura A, Sasaki A, Amano S, Yoshida K, Otomo A, Ohtsuka M, Hadano S. Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B. PLoS One 2020; 15:e0234180. [PMID: 32511278 PMCID: PMC7279612 DOI: 10.1371/journal.pone.0234180] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2019] [Accepted: 05/20/2020] [Indexed: 12/20/2022] Open
Abstract
The autophagy-endolysosomal pathway is an evolutionally conserved degradation system that is tightly linked to a wide variety of physiological processes. Dysfunction of this system is associated with many pathological conditions such as cancer, inflammation and neurodegenerative diseases. Therefore, monitoring the cellular autophagy-endolysosomal activity is crucial for studies on the pathogenesis as well as therapeutics of such disorders. To this end, we here sought to create a novel means exploiting Keima, an acid-stable fluorescent protein possessing pH-dependent fluorescence excitation spectra, for precisely monitoring the autophagy-endolysosomal system. First, we generated three lines of transgenic (tg) mouse expressing monomeric Keima-fused MAP1LC3B (mKeima-LC3B). Then, these tg mice were subjected to starvation by food-restriction, and also challenged to neurodegeneration by genetically crossing with a mouse model of amyotrophic lateral sclerosis; i.e., SOD1H46R transgenic mouse. Unexpectedly, despite that a lipidated-form of endogenous LC3 (LC3-II) was significantly increased, those of mKeima-LC3B (mKeima-LC3B-II) were not changed under both stressed conditions. It was also noted that mKeima-LC3B-positive aggregates were progressively accumulated in the spinal cord of SOD1H46R;mKeima-LC3B double-tg mice, suggestive of acid-resistance and aggregate-prone natures of long-term overexpressed mKeima-LC3B in vivo. Next, we characterized mouse embryonic fibroblasts (MEFs) derived from mKeima-LC3B-tg mice. In contrast with in vivo, levels of mKeima-LC3B-I were decreased under starved conditions. Furthermore, when starved MEFs were treated with chloroquine (CQ), the abundance of mKeima-LC3B-II was significantly increased. Remarkably, when cultured medium was repeatedly changed between DMEM (nutrient-rich) and EBSS (starvation), acidic/neutral signal ratios of mKeima-LC3B-positive compartments were rapidly and reversibly shifted, which were suppressed by the CQ treatment, indicating that intraluminal pH of mKeima-LC3B-positive vesicles was changeable upon nutritional conditions of culture media. Taken together, although mKeima-LC3B-tg mice may not be an appropriate tool to monitor the autophagy-endolysosomal system in vivo, mKeima-LC3B must be one of the most sensitive reporter molecules for monitoring this system under in vitro cultured conditions.
Collapse
Affiliation(s)
- Hideki Hayashi
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Ting Wang
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Masayuki Tanaka
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Sanae Ogiwara
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Masatoshi Ito
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Nahoko Fukunishi
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Yumi Iida
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Ayaka Nakamura
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Ayumi Sasaki
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Shunji Amano
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Kazuhiro Yoshida
- Support Center for Medical Research and Education, Isehara Research Promotion Division, Tokai University, Isehara, Kanagawa, Japan
| | - Asako Otomo
- Molecular Neuropathobiology Laboratory, Department of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa, Japan
- The Institute of Medical Sciences, Tokai University, Isehara, Kanagawa, Japan
- Micro/Nano Technology Center, Tokai University, Hiratsuka, Kanagawa, Japan
| | - Masato Ohtsuka
- Genetic Engineering and Genome Editing Laboratory, Department of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - Shinji Hadano
- Molecular Neuropathobiology Laboratory, Department of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa, Japan
- The Institute of Medical Sciences, Tokai University, Isehara, Kanagawa, Japan
- Micro/Nano Technology Center, Tokai University, Hiratsuka, Kanagawa, Japan
- Research Center for Brain and Nervous Diseases, Tokai University Graduate School of Medicine, Isehara, Kanagawa, Japan
- * E-mail:
| |
Collapse
|
9
|
Okada C, Kaps M, Handschuh S, Scarlet D, Aurich C. 61 Low plasma progestin concentration during the early luteal phase impairs equine conceptus development until placentation. Reprod Fertil Dev 2020. [DOI: 10.1071/rdv32n2ab61] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
During the early luteal phase, low progesterone concentrations delay downregulation of endometrial progesterone receptors. This contributes to impaired histotroph production at Day 14 of pregnancy (Beyer et al. 2019 Theriogenology 125, 236-241). Until the beginning of placentation (i.e. Day 37 of pregnancy), nutritional supply of the equine conceptus depends on histotrophy alone. The aim of the present study was to analyse development of the equine conceptus under reduced plasma progesterone concentrations until shortly before placentation. Fertile Haflinger mares (n=11; 4-11 years old) were examined daily by transrectal ultrasonography, and when in oestrus, they were inseminated every 48h until spontaneous ovulation. Mares were randomly assigned to either the treatment group and received the prostaglandin F2α agonist cloprostenol (PGF2α; 125μg) once daily for 3 days after ovulation (Beyer et al. 2019) or the control group and left untreated. After conceptus collection on Day 34, mares were allowed one oestrous cycle for recovery and subsequently assigned to the opposite treatment, thus serving as their own controls. From Day 10 after ovulation, conceptus development including size, uterine fixation, and heartbeat detection was evaluated daily by transrectal ultrasonography. On Day 34, conceptus and fetal membranes were recovered transcervically. The recovered material was weighed, measured, and stored for further analysis. Conceptuses underwent microcomputed tomography that was evaluated by Amira (Thermo Fisher Scientific). Statistical comparison for differences between control and treatment pregnancies was performed by nonparametric Wilcoxon test or chi-square analysis. The day of first visualisation of the conceptus and of the embryo proper and heartbeat did not differ between treatments. Uterine fixation occurred on Day 19.3±0.5 in conceptuses from PGF2α-treated pregnancies but on Day 16.7±0.4 in controls (P<0.05). At 34 days of gestation, the conceptuses from PGF2α-treated mares were smaller (P<0.05) than control conceptuses when measured with ultrasound callipers in utero (maximal length: PGF2α 17.4±0.3mm, control 19.0±0.4mm). Conceptus weight determined after recovery was less in treated pregnancies (PGF2α 2.5±0.2 g; control 3.5±0.3 g; P<0.05). Microcomputed tomography analysis of selected inner organs showed some differences in development. Seven complete pairs of undestroyed conceptuses were available. Mean numbers of 33.4±3.2 and 18.8±7.5 bronchi were detected in control and PGF2α conceptuses, respectively (P<0.05). Heart volume did not differ, but communication between ventricles was detected in only 1/7 control but 5/7 PGF2α conceptuses (P<0.05). The footpad was present in 6/7 control and 0/7 PGF2α conceptuses (P<0.001). In conclusion, subphysiological progesterone concentration during the early luteal phase delays development of the equine conceptus before placentation. The condition may contribute to early conceptus loss in horses, which occurs in up to 20% of pregnancies.
Collapse
|
10
|
Iijima Y, Tanaka M, Suzuki S, Hauser D, Tanaka M, Okada C, Ito M, Ayukawa N, Sato Y, Ohtsuka M, Scheiffele P, Iijima T. SAM68-Specific Splicing Is Required for Proper Selection of Alternative 3' UTR Isoforms in the Nervous System. iScience 2019; 22:318-335. [PMID: 31805436 PMCID: PMC6909182 DOI: 10.1016/j.isci.2019.11.028] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2019] [Revised: 07/09/2019] [Accepted: 11/13/2019] [Indexed: 12/22/2022] Open
Abstract
Neuronal alternative splicing is a core mechanism for functional diversification. We previously found that STAR family proteins (SAM68, SLM1, SLM2) regulate spatiotemporal alternative splicing in the nervous system. However, the whole aspect of alternative splicing programs by STARs remains unclear. Here, we performed a transcriptomic analysis using SAM68 knockout and SAM68/SLM1 double-knockout midbrains. We revealed different alternative splicing activity between SAM68 and SLM1; SAM68 preferentially targets alternative 3′ UTR exons. SAM68 knockout causes a long-to-short isoform switch of a number of neuronal targets through the alteration in alternative last exon (ALE) selection or alternative polyadenylation. The altered ALE usage of a novel target, interleukin 1 receptor accessory protein (Il1rap), results in remarkable conversion from a membrane-bound type to a secreted type in Sam68KO brains. Proper ALE selection is necessary for IL1RAP neuronal function. Thus the SAM68-specific splicing program provides a mechanism for neuronal selection of alternative 3′ UTR isoforms. SAM68 and the related protein SLM1 exhibit distinct alternative splicing activity SAM68 specifically controls 3′ UTR selection of multiple neuronal genes Proper 3′ UTR selection is necessary for IL1RAP neuronal function Neuronal expression of SAM68 requires proper 3′ UTR selection in the nervous system
Collapse
Affiliation(s)
- Yoko Iijima
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan; Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, 143, Shimokasuya, Isehara, Kanagawa 259-1193, Japan
| | - Masami Tanaka
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan
| | - Satoko Suzuki
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan
| | - David Hauser
- Biozentrum, University of Basel, Klingelbergstrasse 50-70, Basel 4056, Switzerland
| | - Masayuki Tanaka
- The Support Center for Medical Research and Education, Tokai University, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan
| | - Chisa Okada
- The Support Center for Medical Research and Education, Tokai University, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan
| | - Masatoshi Ito
- The Support Center for Medical Research and Education, Tokai University, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan
| | - Noriko Ayukawa
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan
| | - Yuji Sato
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan; Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, 143, Shimokasuya, Isehara, Kanagawa 259-1193, Japan
| | - Masato Ohtsuka
- Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, 143, Shimokasuya, Isehara, Kanagawa 259-1193, Japan
| | - Peter Scheiffele
- Biozentrum, University of Basel, Klingelbergstrasse 50-70, Basel 4056, Switzerland
| | - Takatoshi Iijima
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan; Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, School of Medicine, Tokai University, 143, Shimokasuya, Isehara, Kanagawa 259-1193, Japan.
| |
Collapse
|
11
|
Kakimoto Y, Okada C, Kawabe N, Sasaki A, Tsukamoto H, Nagao R, Osawa M. Myocardial lipofuscin accumulation in ageing and sudden cardiac death. Sci Rep 2019; 9:3304. [PMID: 30824797 PMCID: PMC6397159 DOI: 10.1038/s41598-019-40250-0] [Citation(s) in RCA: 46] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2018] [Accepted: 02/12/2019] [Indexed: 01/10/2023] Open
Abstract
Lipofuscin is an intracellular aggregate of highly oxidized proteins that cannot be digested in the ubiquitin-proteasome system and accumulate mainly in lysosomes, especially in aged cells and pathological conditions. However, no systematic study has evaluated the cardiac accumulation of lipofuscin during human ageing and sudden cardiac death (SCD). Age estimation in unidentified bodies and postmortem SCD diagnosis are important themes in forensics. Thus, we aimed to elucidate their correlations with myocardial lipofuscin accumulation. We collected 76 cardiac samples from autopsy patients aged 20–97 years. After histopathological examination, myocardial lipofuscin was measured using its autofluorescence. Lipofuscin accumulated mainly in the perinuclear zone, and its accumulation rate positively correlated with chronological ageing (r = 0.82). Meanwhile, no significant change in lipofuscin level was observed with different causes of death, including SCD. There was also no significant change in lipofuscin level in relation to body mass index, serum brain natriuretic peptide level, or heart weight. Moreover, we performed LC3 and p62 immunoblotting to evaluate autophagic activity, and no change was observed in ageing. Therefore, lipofuscin accumulation more directly reflects chronological ageing rather than human cardiac pathology. Our study reveals the stability and utility of cardiac lipofuscin measurement for age estimation during autopsy.
Collapse
Affiliation(s)
- Yu Kakimoto
- Department of Forensic Medicine, Tokai University School of Medicine, Kanagawa, Japan.
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University, Kanagawa, Japan
| | - Noboru Kawabe
- Support Center for Medical Research and Education, Tokai University, Kanagawa, Japan
| | - Ayumi Sasaki
- Support Center for Medical Research and Education, Tokai University, Kanagawa, Japan
| | - Hideo Tsukamoto
- Support Center for Medical Research and Education, Tokai University, Kanagawa, Japan
| | - Ryoko Nagao
- Department of Forensic Medicine, Tokai University School of Medicine, Kanagawa, Japan
| | - Motoki Osawa
- Department of Forensic Medicine, Tokai University School of Medicine, Kanagawa, Japan
| |
Collapse
|
12
|
Salybekov AA, Kawaguchi AT, Masuda H, Vorateera K, Okada C, Asahara T. Regeneration-associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti-inflammation, and cardiomyogenesis. PLoS One 2018; 13:e0203244. [PMID: 30485279 PMCID: PMC6261405 DOI: 10.1371/journal.pone.0203244] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2018] [Accepted: 10/23/2018] [Indexed: 11/18/2022] Open
Abstract
Background Considering the impaired function of regenerative cells in myocardial infarction (MI) patients with comorbidities and associated risk factors, cell therapy to enhance the regenerative microenvironment was designed using regeneration-associated cells (RACs), including endothelial progenitor cells (EPCs) and anti-inflammatory cells. Methods RACs were prepared by quality and quantity control culture of blood mononuclear cells (QQMNCs). Peripheral blood mononuclear cells (PBMNCs) were isolated from Lewis rats and conditioned for 5 days using a medium containing stem cell factors, thrombopoietin, Flt-3 ligand, vascular endothelial growth factor, and interleukin-6 to generate QQMNCs. Results A 5.3-fold increase in the definitive colony-forming EPCs and vasculogenic EPCs was observed, in comparison to naïve PBMNCs. QQMNCs were enriched with EPCs (28.9-fold, P<0.0019) and M2 macrophages (160.3-fold, P<0.0002). Genes involved in angiogenesis (angpt1, angpt2, and vegfb), stem/progenitors (c-kit and sca-1), and anti-inflammation (arg-1, erg-2, tgfb, and foxp3) were upregulated in QQMNCs. For in vivo experiments, cells were administered into syngeneic rat models of MI. QQMNC-transplanted group (QQ-Tx) preserved cardiac function and fraction shortening 28 days post-MI in comparison with PBMNCs-transplanted (PB-Tx) (P<0.0001) and Control (P<0.0008) groups. QQ-Tx showed enhanced angiogenesis and reduced interstitial left ventricular fibrosis, along with a decrease in neutrophils and an increase in M2 macrophages in the acute phase of MI. Cell tracing studies revealed that intravenously administered QQMNCs preferentially homed to ischemic tissues via blood circulation. QQ-Tx showed markedly upregulated early cardiac transcriptional cofactors (Nkx2-5, 29.8-fold, and Gata-4, 5.2-fold) as well as c-kit (4.5-fold) while these markers were downregulated in PB-Tx. In QQ-Tx animals, de novo blood vessels formed a “Biological Bypass”, observed macroscopically and microscopically, while PB-Tx and Control-Tx groups showed severe fibrotic adhesion to the surrounding tissues, but no epicardial blood vessels. Conclusion QQMNCs conferred potent angiogenic and anti-inflammatory properties to the regenerative microenvironment, enhancing myocardiogenesis and functional recovery of rat MI hearts.
Collapse
Affiliation(s)
- Amankeldi A. Salybekov
- Department of Regenerative Medicine Science, Tokai University School of Medicine, Isehara, Japan
| | - Akira T. Kawaguchi
- Department of Regenerative Medicine Science, Tokai University School of Medicine, Isehara, Japan
| | - Haruchika Masuda
- Department of Physiology, Tokai University School of Medicine, Isehara, Japan
| | - Kosit Vorateera
- Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi, Thailand
| | - Chisa Okada
- Teaching and Research Support Core Center, Tokai University School of Medicine, Isehara, Japan
| | - Takayuki Asahara
- Department of Regenerative Medicine Science, Tokai University School of Medicine, Isehara, Japan
- * E-mail:
| |
Collapse
|
13
|
Mizuguchi Y, Maruta M, Moriyama S, Yamashita N, Okada C, Nishimura A, Fujiwara Y, Tahakashi A. P5434Evaluation of the determinant factors on the capacity for self-care in patients with acute myocardial infarction. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p5434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | - M Maruta
- Sakurakai Takahashi Hospital, Kobe, Japan
| | - S Moriyama
- Sakurakai Takahashi Hospital, Kobe, Japan
| | | | - C Okada
- Sakurakai Takahashi Hospital, Kobe, Japan
| | | | - Y Fujiwara
- Sakurakai Takahashi Hospital, Kobe, Japan
| | | |
Collapse
|
14
|
Owada S, Endo H, Shida Y, Okada C, Ito K, Nezu T, Tatemichi M. Autophagy‑mediated adaptation of hepatocellular carcinoma cells to hypoxia‑mimicking conditions constitutes an attractive therapeutic target. Oncol Rep 2018; 39:1805-1812. [PMID: 29484444 DOI: 10.3892/or.2018.6279] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2017] [Accepted: 01/31/2018] [Indexed: 11/06/2022] Open
Abstract
Hepatocellular carcinoma has extremely poor prognosis. In cancerous liver tissues, aberrant proliferation of cancer cells leads to the creation of an area where an immature vascular network is formed. Since oxygen is supplied to cancer tissues through the bloodstream, a part of the tumor is exposed to hypoxic conditions. As hypoxia is known to severely reduce the effectiveness of existing anticancer agents, novel valid therapeutic targets must be identified for the treatment of hepatocellular carcinoma. Generally, autophagy has been reported to play an important role in the adaptation of cancer cells to hypoxia. However, the exact role and significance of this process vary depending on the cancer type, requiring detailed analysis in individual primary tumors and cell lines. In the present study, we examined autophagy induced by cobalt chloride, a hypoxia‑mimicking agent, in hepatocellular carcinoma cells with the aim to evaluate the validity of this process as a potential therapeutic target. We observed that treatment with cobalt chloride induced autophagy, including the intracellular quality control mechanism, in an AMPK‑dependent manner. Furthermore, treatment with autophagy inhibitors (bafilomycin and LY294002) resulted in significant, highly‑selective cytotoxicity and apoptosis activation under hypoxia‑mimicking conditions. The knockdown of AMPK also revealed significant cytotoxicity in hypoxia‑mimicking conditions. These results clearly demonstrated that autophagy, especially mitophagy, was induced by the AMPK pathway when hepatocellular carcinoma cells were subjected to hypoxic conditions and played an important role in the adaptation of these cells to such conditions. Thus, autophagy may constitute an attractive therapeutic target for the treatment of hepatocellular carcinoma.
Collapse
Affiliation(s)
- Satoshi Owada
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259‑1193, Japan
| | - Hitoshi Endo
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259‑1193, Japan
| | - Yukari Shida
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259‑1193, Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University, Isehara, Kanagawa 259‑1193, Japan
| | - Kanako Ito
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259‑1193, Japan
| | - Takahiro Nezu
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259‑1193, Japan
| | - Masayuki Tatemichi
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259‑1193, Japan
| |
Collapse
|
15
|
Yamaguchi S, Okada C, Watanabe Y, Watanabe M, Hattori Y. Analysis of masticatory muscle coordination during unilateral single-tooth clenching using muscle functional magnetic resonance imaging. J Oral Rehabil 2017; 45:9-16. [PMID: 29090477 DOI: 10.1111/joor.12583] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/26/2017] [Indexed: 12/15/2022]
Abstract
In a previous study, we used muscle functional magnetic resonance imaging to show that the anterior movement of the occlusal point increased the activity of the superior head of the ipsilateral lateral pterygoid muscle (ipsilateral SHLP) during unilateral single-tooth clenching. The purpose of this study was to verify the hypothesis that the increased activity of the ipsilateral SHLP described above serves to antagonise the occlusal force acting on the condyle. In total, 9 healthy volunteers were requested to perform left unilateral clenching at the first molar or first premolar region for 1 minute at 20% or 40% maximum voluntary clenching force. Changes in the mean proton transverse relaxation time (∆T2) were examined from the magnetic resonance images obtained before and after each clenching act as an index of the activity in all masticatory muscles. Correlation analyses of the mean ΔT2 for each volume of interest were performed with the first molar or premolar clenches to analyse the correlation between the activities in each muscle. A statistically significant correlation was exhibited between the ipsilateral temporal and ipsilateral SHLP (r = .651, P = .003) during first premolar clenching. However, no significant correlations were observed in the ipsilateral SHLP during first molar clenching. The results of this study suggest that the ipsilateral SHLP may contribute to the pulling of the mandibular condyle forward against the occlusal force generated by the ipsilateral temporal muscle.
Collapse
Affiliation(s)
- S Yamaguchi
- Division of Aging and Geriatric Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan
| | - C Okada
- Division of Aging and Geriatric Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan
| | - Y Watanabe
- Department of Health Services Management, Faculty of Health Sciences, Tohoku Fukushi University, Sendai, Japan.,Kansei Fukushi Research Center, Tohoku Fukushi University, Sendai, Japan
| | - M Watanabe
- Division of Aging and Geriatric Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan.,Kansei Fukushi Research Center, Tohoku Fukushi University, Sendai, Japan
| | - Y Hattori
- Division of Aging and Geriatric Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan
| |
Collapse
|
16
|
Owada S, Ito K, Endo H, Shida Y, Okada C, Nezu T, Tatemichi M. An Adaptation System to Avoid Apoptosis via Autophagy Under Hypoxic Conditions in Pancreatic Cancer Cells. Anticancer Res 2017; 37:4927-4934. [PMID: 28870914 DOI: 10.21873/anticanres.11902] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2017] [Revised: 07/20/2017] [Accepted: 07/21/2017] [Indexed: 12/20/2022]
Abstract
BACKGROUND/AIM Pancreatic cancer tissue is a hypoxic environment resistant to anticancer drugs. This study examined the role of autophagy as a response to hypoxic stress in pancreatic cancer. MATERIALS AND METHODS Pancreatic cell lines (PANC-1, BxPC-3 and AsPC-1) were exposed to hypoxic conditions using cobalt chloride, a hypoxia-mimicking agent. Protein expression and cytotoxicity assays were performed to determine the effect of hypoxia on autophagy. RESULTS When pancreatic cancer cells were exposed to hypoxia, autophagy was induced. The autophagy-inducing signal was dependent on the AMPK pathway. Inhibition of autophagy in a hypoxic state induced a remarkable cytotoxicity and enhanced apoptosis. When an AMPK inhibitor was added, cytotoxicity was observed in the hypoxic environment. CONCLUSION The induced autophagy, dependent on the AMPK pathway, is a necessary survival strategy adopted by pancreatic cancer cells to adapt to hypoxic stress, and could be an attractive target for drug development.
Collapse
Affiliation(s)
- Satoshi Owada
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan
| | - Kanako Ito
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan
| | - Hitoshi Endo
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan
| | - Yukari Shida
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University, Isehara, Japan
| | - Takahiro Nezu
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan
| | - Masayuki Tatemichi
- Center for Molecular Prevention and Environmental Medicine, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan
| |
Collapse
|
17
|
Suzuki S, Ayukawa N, Okada C, Tanaka M, Takekoshi S, Iijima Y, Iijima T. Spatio-temporal and dynamic regulation of neurofascin alternative splicing in mouse cerebellar neurons. Sci Rep 2017; 7:11405. [PMID: 28900163 PMCID: PMC5595909 DOI: 10.1038/s41598-017-11319-5] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2017] [Accepted: 08/22/2017] [Indexed: 12/13/2022] Open
Abstract
Alternative splicing is crucial for molecular diversification, which greatly contributes to the complexity and specificity of neural functions in the central nervous system (CNS). Neurofascin (NF) is a polymorphic cell surface protein that has a number of splicing isoforms. As the alternative splicing of the neurofascin gene (Nfasc) is developmentally regulated, NF isoforms have distinct functions in immature and mature brains. However, the molecular mechanisms underlying the alternative splicing of Nfasc in neurons are not yet understood. Here, we demonstrate that, alongside developmental regulation, Nfasc alternative splicing is spatially controlled in the mouse brain. We then identified distinct Nfasc splicing patterns at the cell-type level in the cerebellum, with Nfasc186 being expressed in Purkinje cells and absent from granule cells (GCs). Furthermore, we show that high K+-induced depolarization triggers a shift in splicing from Nfasc140 to Nfasc186 in cerebellar GCs. Finally, we identified a neural RNA-binding protein, Rbfox, as a key player in neural NF isoform selection, specifically controlling splicing at exons 26−29. Together, our results show that Nfasc alternative splicing is spatio-temporally and dynamically regulated in cerebellar neurons. Our findings provide profound insight into the mechanisms underlying the functional diversity of neuronal cell-adhesive proteins in the mammalian CNS.
Collapse
Affiliation(s)
- Satoko Suzuki
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan; and 411 Kitakaname, Hiratsuka City, Kanagawa, 259-1292, Japan
| | - Noriko Ayukawa
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan; and 411 Kitakaname, Hiratsuka City, Kanagawa, 259-1292, Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University, 143 Shimokasuya, Isehara City, Kanagawa, 259-1193, Japan
| | - Masami Tanaka
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan; and 411 Kitakaname, Hiratsuka City, Kanagawa, 259-1292, Japan
| | - Susumu Takekoshi
- Department of Cell Biology, Division of Host Defense Mechanism, School of Medicine, Tokai University, 143 Shimokasuya, Isehara City, Kanagawa, 259-1193, Japan
| | - Yoko Iijima
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan; and 411 Kitakaname, Hiratsuka City, Kanagawa, 259-1292, Japan
| | - Takatoshi Iijima
- Tokai University Institute of Innovative Science and Technology, 143 Shimokasuya, Isehara City, Kanagawa 259-1193, Japan; and 411 Kitakaname, Hiratsuka City, Kanagawa, 259-1292, Japan.
| |
Collapse
|
18
|
Akatsuka H, Kuga S, Masuhara K, Davaadorj O, Okada C, Iida Y, Okada Y, Fukunishi N, Suzuki T, Hosomichi K, Ohtsuka M, Tanaka M, Inoue I, Kimura M, Sato T. AMBRA1 is involved in T cell receptor-mediated metabolic reprogramming through an ATG7-independent pathway. Biochem Biophys Res Commun 2017; 491:1098-1104. [PMID: 28789945 DOI: 10.1016/j.bbrc.2017.08.019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2017] [Accepted: 08/04/2017] [Indexed: 11/30/2022]
Abstract
Metabolic reprogramming contributes to dynamic alteration of cell functions and characteristics. In T cells, TCR-mediated signaling evokes metabolic reprogramming and autophagy. AMBRA1 is known to serve in the facilitation of autophagy and quality control of mitochondria, but the role of AMBRA1 in T cell metabolic alteration is unknown. Here, we show that AMBRA1, but not ATG7, plays a role in TCR-mediated control of glycolytic factors and mitochondrial mass, while both AMBRA1 and ATG7 are required for autolysosome formation. Our results suggested that AMBRA1 is a core factor that controls both autophagy and metabolic regulation.
Collapse
Affiliation(s)
- Hisako Akatsuka
- Department of Host Defense Mechanism, Japan; Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Japan
| | | | - Kaori Masuhara
- Department of Host Defense Mechanism, Japan; Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Japan
| | - Odontuya Davaadorj
- Department of Host Defense Mechanism, Japan; Department of Ophthalmology, Tokai University School of Medicine, Kanagawa, Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University, Kanagawa, Japan
| | - Yumi Iida
- Support Center for Medical Research and Education, Tokai University, Kanagawa, Japan
| | - Yoshinori Okada
- Support Center for Medical Research and Education, Tokai University, Kanagawa, Japan
| | - Nahoko Fukunishi
- Support Center for Medical Research and Education, Tokai University, Kanagawa, Japan
| | - Takahiro Suzuki
- Department of Ophthalmology, Tokai University School of Medicine, Kanagawa, Japan
| | - Kazuyoshi Hosomichi
- Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan; Division of Human Genetics, Department of Integrated Genetics, National Institute of Genetics, Mishima, Shizuoka, Japan
| | - Masato Ohtsuka
- Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Japan
| | - Masafumi Tanaka
- Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Japan
| | - Ituro Inoue
- Division of Human Genetics, Department of Integrated Genetics, National Institute of Genetics, Mishima, Shizuoka, Japan
| | - Minoru Kimura
- Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Japan
| | | |
Collapse
|
19
|
Okada C, Yamaguchi S, Watanabe Y, Watanabe M, Hattori Y. Evaluation of masticatory activity during unilateral single tooth clenching using muscle functional magnetic resonance imaging. J Oral Rehabil 2016; 43:583-90. [PMID: 27113040 DOI: 10.1111/joor.12404] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/27/2016] [Indexed: 11/30/2022]
Abstract
Masticatory muscle activity during teeth clenching is affected by occlusal pattern. However, few studies have performed simultaneous evaluation of all masticatory activities during teeth clenching under various occlusal conditions. The aim of this study was to use muscle functional magnetic resonance imaging (mfMRI) to evaluate the effects of changes in occlusal point on masticatory activity during single tooth clenching. Changes in mean proton transverse relaxation time (∆T2) as an index of activity in all masticatory muscles during left unilateral clenching at the first molar or first premolar for 1 min were examined in nine healthy volunteers. Bite force was maintained at 40% of the maximum voluntary clenching force. The ∆T2 values of the masseter and lateral pterygoid muscles were analysed separately for superficial and deep layers, and for superior and inferior heads. The ∆T2 values for the ipsilateral deep masseter were significantly lower, and for the superior head of the ipsilateral lateral pterygoid muscles were significantly higher, after left first premolar clenching compared to left first molar clenching. These results quantitatively demonstrate a significant increase in activity of the superior head of the ipsilateral lateral pterygoid muscle and a significant decrease in activity of the ipsilateral deep masseter muscle with forward displacement of the occlusal contact point during unilateral tooth clenching.
Collapse
Affiliation(s)
- C Okada
- Division of Aging and Geriatric Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan
| | - S Yamaguchi
- Division of Aging and Geriatric Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan
| | - Y Watanabe
- Department of Health Services Management, Faculty of Health Sciences, Tohoku Fukushi University, Sendai, Japan
| | - M Watanabe
- Division of Aging and Geriatric Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan.,Kansei Fukushi Research Center, Tohoku Fukushi University, Sendai, Japan
| | - Y Hattori
- Division of Aging and Geriatric Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan
| |
Collapse
|
20
|
Ajello M, Albert A, Anderson B, Baldini L, Barbiellini G, Bastieri D, Bellazzini R, Bissaldi E, Blandford RD, Bloom ED, Bonino R, Bottacini E, Bregeon J, Bruel P, Buehler R, Caliandro GA, Cameron RA, Caragiulo M, Caraveo PA, Cecchi C, Chekhtman A, Ciprini S, Cohen-Tanugi J, Conrad J, Costanza F, D'Ammando F, de Angelis A, de Palma F, Desiante R, Di Mauro M, Di Venere L, Domínguez A, Drell PS, Favuzzi C, Focke WB, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Glanzman T, Godfrey G, Guiriec S, Horan D, Jóhannesson G, Katsuragawa M, Kensei S, Kuss M, Larsson S, Latronico L, Li J, Li L, Longo F, Loparco F, Lubrano P, Madejski GM, Maldera S, Manfreda A, Mayer M, Mazziotta MN, Meyer M, Michelson PF, Mirabal N, Mizuno T, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Negro M, Nuss E, Okada C, Orlando E, Ormes JF, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Reimer A, Sánchez-Conde M, Sgrò C, Simone D, Siskind EJ, Spada F, Spandre G, Spinelli P, Takahashi H, Thayer JB, Torres DF, Tosti G, Troja E, Uchiyama Y, Wood KS, Wood M, Zaharijas G, Zimmer S. Search for Spectral Irregularities due to Photon-Axionlike-Particle Oscillations with the Fermi Large Area Telescope. Phys Rev Lett 2016; 116:161101. [PMID: 27152783 DOI: 10.1103/physrevlett.116.161101] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/27/2015] [Indexed: 06/05/2023]
Abstract
We report on the search for spectral irregularities induced by oscillations between photons and axionlike-particles (ALPs) in the γ-ray spectrum of NGC 1275, the central galaxy of the Perseus cluster. Using 6 years of Fermi Large Area Telescope data, we find no evidence for ALPs and exclude couplings above 5×10^{-12} GeV^{-1} for ALP masses 0.5≲m_{a}≲5 neV at 95% confidence. The limits are competitive with the sensitivity of planned laboratory experiments, and, together with other bounds, strongly constrain the possibility that ALPs can reduce the γ-ray opacity of the Universe.
Collapse
Affiliation(s)
- M Ajello
- Department of Physics and Astronomy, Clemson University, Kinard Lab of Physics, Clemson, South Carolina 29634-0978, USA
| | - A Albert
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - B Anderson
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - L Baldini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Università di Pisa and Istituto Nazionale di Fisica Nucleare, Sezione di Pisa I-56127 Pisa, Italy
| | - G Barbiellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - D Bastieri
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei," Università di Padova, I-35131 Padova, Italy
| | - R Bellazzini
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E Bissaldi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - R D Blandford
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - E D Bloom
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - R Bonino
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale "Amadeo Avogadro," Università degli Studi di Torino, I-10125 Torino, Italy
| | - E Bottacini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - J Bregeon
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - P Bruel
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - R Buehler
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - G A Caliandro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Consorzio Interuniversitario per la Fisica Spaziale (CIFS), I-10133 Torino, Italy
| | - R A Cameron
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - M Caragiulo
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P A Caraveo
- INAF-Istituto di Astrofisica Spaziale e Fisica Cosmica, I-20133 Milano, Italy
| | - C Cecchi
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - A Chekhtman
- College of Science, George Mason University, Fairfax, Virginia 22030, USA and Naval Research Laboratory, Washington, D.C. 20375, USA
| | - S Ciprini
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
| | - J Cohen-Tanugi
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - J Conrad
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - F Costanza
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - F D'Ammando
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
- Dipartimento di Astronomia, Università di Bologna, I-40127 Bologna, Italy
| | - A de Angelis
- Dipartimento di Fisica, Università di Udine and Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Gruppo Collegato di Udine, I-33100 Udine
| | - F de Palma
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Università Telematica Pegaso, Piazza Trieste e Trento, 48, I-80132 Napoli, Italy
| | - R Desiante
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Università di Udine, I-33100 Udine, Italy
| | - M Di Mauro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - L Di Venere
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - A Domínguez
- Department of Physics and Astronomy, Clemson University, Kinard Lab of Physics, Clemson, South Carolina 29634-0978, USA
| | - P S Drell
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - C Favuzzi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - W B Focke
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A Franckowiak
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - Y Fukazawa
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - S Funk
- Erlangen Centre for Astroparticle Physics, D-91058 Erlangen, Germany
| | - P Fusco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - F Gargano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - D Gasparrini
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
| | - N Giglietto
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - T Glanzman
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G Godfrey
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - S Guiriec
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - D Horan
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - G Jóhannesson
- Science Institute, University of Iceland, IS-107 Reykjavik, Iceland
| | - M Katsuragawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo-ku, Sagamihara, Kanagawa 252-5210, Japan
| | - S Kensei
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - M Kuss
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - S Larsson
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
| | - L Latronico
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - J Li
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
| | - L Li
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
| | - F Longo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - F Loparco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P Lubrano
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - G M Madejski
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - S Maldera
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - A Manfreda
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - M Mayer
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M N Mazziotta
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - M Meyer
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - P F Michelson
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - N Mirabal
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - T Mizuno
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - M E Monzani
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - A Morselli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma "Tor Vergata," I-00133 Roma, Italy
| | - I V Moskalenko
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - S Murgia
- Center for Cosmology, Physics and Astronomy Department, University of California, Irvine, California 92697-2575, USA
| | - M Negro
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale "Amadeo Avogadro," Università degli Studi di Torino, I-10125 Torino, Italy
| | - E Nuss
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - C Okada
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - E Orlando
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Denver, Colorado 80208, USA
| | - D Paneque
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Max-Planck-Institut für Physik, D-80805 München, Germany
| | - J S Perkins
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - M Pesce-Rollins
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - F Piron
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - G Pivato
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - T A Porter
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - S Rainò
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - R Rando
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei," Università di Padova, I-35131 Padova, Italy
| | - M Razzano
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - A Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - M Sánchez-Conde
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - C Sgrò
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - D Simone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - E J Siskind
- NYCB Real-Time Computing Inc., Lattingtown, New York 11560-1025, USA
| | - F Spada
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G Spandre
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - P Spinelli
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - H Takahashi
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - J B Thayer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - D F Torres
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
| | - G Tosti
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - E Troja
- NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Uchiyama
- Department of Physics, 3-34-1 Nishi-Ikebukuro, Toshima-ku, Tokyo 171-8501, Japan
| | - K S Wood
- Space Science Division, Naval Research Laboratory, Washington, D.C. 20375-5352, USA
| | - M Wood
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA
| | - G Zaharijas
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, and Università di Trieste, I-34127 Trieste, Italy
- Laboratory for Astroparticle Physics, University of Nova Gorica, Vipavska 13, SI-5000 Nova Gorica, Slovenia
| | - S Zimmer
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| |
Collapse
|
21
|
Ackermann M, Ajello M, Albert A, Atwood WB, Baldini L, Ballet J, Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Bissaldi E, Blandford RD, Bloom ED, Bonino R, Bregeon J, Britto RJ, Bruel P, Buehler R, Caliandro GA, Cameron RA, Caragiulo M, Caraveo PA, Cavazzuti E, Cecchi C, Charles E, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Cohen-Tanugi J, Cominsky LR, Costanza F, Cutini S, D'Ammando F, de Angelis A, de Palma F, Desiante R, Digel SW, Di Mauro M, Di Venere L, Domínguez A, Drell PS, Favuzzi C, Fegan SJ, Ferrara EC, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giommi P, Giordano F, Giroletti M, Godfrey G, Green D, Grenier IA, Guiriec S, Hays E, Horan D, Iafrate G, Jogler T, Jóhannesson G, Kuss M, La Mura G, Larsson S, Latronico L, Li J, Li L, Longo F, Loparco F, Lott B, Lovellette MN, Lubrano P, Madejski GM, Magill J, Maldera S, Manfreda A, Mayer M, Mazziotta MN, Michelson PF, Mitthumsiri W, Mizuno T, Moiseev AA, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Negro M, Nuss E, Ohsugi T, Okada C, Omodei N, Orlando E, Ormes JF, Paneque D, Perkins JS, Pesce-Rollins M, Petrosian V, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Reposeur T, Romani RW, Sánchez-Conde M, Schmid J, Schulz A, Sgrò C, Simone D, Siskind EJ, Spada F, Spandre G, Spinelli P, Suson DJ, Takahashi H, Thayer JB, Tibaldo L, Torres DF, Troja E, Vianello G, Yassine M, Zimmer S. Resolving the Extragalactic γ-Ray Background above 50 GeV with the Fermi Large Area Telescope. Phys Rev Lett 2016; 116:151105. [PMID: 27127954 DOI: 10.1103/physrevlett.116.151105] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/24/2015] [Indexed: 05/16/2023]
Abstract
The Fermi Large Area Telescope (LAT) Collaboration has recently released a catalog of 360 sources detected above 50 GeV (2FHL). This catalog was obtained using 80 months of data re-processed with Pass 8, the newest event-level analysis, which significantly improves the acceptance and angular resolution of the instrument. Most of the 2FHL sources at high Galactic latitude are blazars. Using detailed Monte Carlo simulations, we measure, for the first time, the source count distribution, dN/dS, of extragalactic γ-ray sources at E>50 GeV and find that it is compatible with a Euclidean distribution down to the lowest measured source flux in the 2FHL (∼8×10^{-12} ph cm^{-2} s^{-1}). We employ a one-point photon fluctuation analysis to constrain the behavior of dN/dS below the source detection threshold. Overall, the source count distribution is constrained over three decades in flux and found compatible with a broken power law with a break flux, S_{b}, in the range [8×10^{-12},1.5×10^{-11}] ph cm^{-2} s^{-1} and power-law indices below and above the break of α_{2}∈[1.60,1.75] and α_{1}=2.49±0.12, respectively. Integration of dN/dS shows that point sources account for at least 86_{-14}^{+16}% of the total extragalactic γ-ray background. The simple form of the derived source count distribution is consistent with a single population (i.e., blazars) dominating the source counts to the minimum flux explored by this analysis. We estimate the density of sources detectable in blind surveys that will be performed in the coming years by the Cherenkov Telescope Array.
Collapse
Affiliation(s)
- M Ackermann
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M Ajello
- Department of Physics and Astronomy, Clemson University, Kinard Lab of Physics, Clemson, SC 29634-0978, USA
| | - A Albert
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - W B Atwood
- Santa Cruz Institute for Particle Physics, Department of Physics and Department of Astronomy and Astrophysics, University of California at Santa Cruz, Santa Cruz, CA 95064, USA
| | - L Baldini
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Università di Pisa and Istituto Nazionale di Fisica Nucleare, Sezione di Pisa I-56127 Pisa, Italy
| | - J Ballet
- Laboratoire AIM, CEA-IRFU/CNRS/Université Paris Diderot, Service d'Astrophysique, CEA Saclay, F-91191 Gif sur Yvette, France
| | - G Barbiellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - D Bastieri
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
| | - K Bechtol
- Dept. of Physics and Wisconsin IceCube Particle Astrophysics Center, University of Wisconsin, Madison, WI 53706, USA
| | - R Bellazzini
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E Bissaldi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - R D Blandford
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - E D Bloom
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - R Bonino
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale "Amadeo Avogadro", Università degli Studi di Torino, I-10125 Torino, Italy
| | - J Bregeon
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - R J Britto
- Department of Physics, University of Johannesburg, PO Box 524, Auckland Park 2006, South Africa
| | - P Bruel
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - R Buehler
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - G A Caliandro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Consorzio Interuniversitario per la Fisica Spaziale (CIFS), I-10133 Torino, Italy
| | - R A Cameron
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M Caragiulo
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P A Caraveo
- INAF-Istituto di Astrofisica Spaziale e Fisica Cosmica, I-20133 Milano, Italy
| | - E Cavazzuti
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
| | - C Cecchi
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - E Charles
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - A Chekhtman
- College of Science, George Mason University, Fairfax, VA 22030, resident at Naval Research Laboratory, Washington, DC 20375, USA
| | - J Chiang
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - G Chiaro
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
| | - S Ciprini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - J Cohen-Tanugi
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - L R Cominsky
- Department of Physics and Astronomy, Sonoma State University, Rohnert Park, CA 94928-3609, USA
| | - F Costanza
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - S Cutini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- INAF Osservatorio Astronomico di Roma, I-00040 Monte Porzio Catone (Roma), Italy
| | - F D'Ammando
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
- Dipartimento di Astronomia, Università di Bologna, I-40127 Bologna, Italy
| | - A de Angelis
- Dipartimento di Fisica, Università di Udine and Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Gruppo Collegato di Udine, I-33100 Udine
| | - F de Palma
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Università Telematica Pegaso, Piazza Trieste e Trento, 48, I-80132 Napoli, Italy
| | - R Desiante
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Università di Udine, I-33100 Udine, Italy
| | - S W Digel
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M Di Mauro
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - L Di Venere
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - A Domínguez
- Department of Physics and Astronomy, Clemson University, Kinard Lab of Physics, Clemson, SC 29634-0978, USA
| | - P S Drell
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - C Favuzzi
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - S J Fegan
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - E C Ferrara
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - A Franckowiak
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - Y Fukazawa
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - S Funk
- Erlangen Centre for Astroparticle Physics, D-91058 Erlangen, Germany
| | - P Fusco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - F Gargano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - D Gasparrini
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
| | - N Giglietto
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - P Giommi
- Agenzia Spaziale Italiana (ASI) Science Data Center, I-00133 Roma, Italy
| | - F Giordano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - M Giroletti
- INAF Istituto di Radioastronomia, I-40129 Bologna, Italy
| | - G Godfrey
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - D Green
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
| | - I A Grenier
- Laboratoire AIM, CEA-IRFU/CNRS/Université Paris Diderot, Service d'Astrophysique, CEA Saclay, F-91191 Gif sur Yvette, France
| | - S Guiriec
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- NASA Postdoctoral Program Fellow, USA
| | - E Hays
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - D Horan
- Laboratoire Leprince-Ringuet, École polytechnique, CNRS/IN2P3, Palaiseau, France
| | - G Iafrate
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Osservatorio Astronomico di Trieste, Istituto Nazionale di Astrofisica, I-34143 Trieste, Italy
| | - T Jogler
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - G Jóhannesson
- Science Institute, University of Iceland, IS-107 Reykjavik, Iceland
| | - M Kuss
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G La Mura
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - S Larsson
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - L Latronico
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - J Li
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
| | - L Li
- Department of Physics, KTH Royal Institute of Technology, AlbaNova, SE-106 91 Stockholm, Sweden
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
| | - F Longo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - F Loparco
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - B Lott
- Centre d'Études Nucléaires de Bordeaux Gradignan, IN2P3/CNRS, Université Bordeaux 1, BP120, F-33175 Gradignan Cedex, France
| | - M N Lovellette
- Space Science Division, Naval Research Laboratory, Washington, DC 20375-5352, USA
| | - P Lubrano
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - G M Madejski
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - J Magill
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
| | - S Maldera
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - A Manfreda
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - M Mayer
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M N Mazziotta
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - P F Michelson
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - W Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - T Mizuno
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - A A Moiseev
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
- Center for Research and Exploration in Space Science and Technology (CRESST) and NASA Goddard Space Flight Center, Greenbelt, Maryland 20771, USA
| | - M E Monzani
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - A Morselli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma "Tor Vergata", I-00133 Roma, Italy
| | - I V Moskalenko
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - S Murgia
- Center for Cosmology, Physics and Astronomy Department, University of California, Irvine, California 92697-2575, USA
| | - M Negro
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
- Dipartimento di Fisica Generale "Amadeo Avogadro", Università degli Studi di Torino, I-10125 Torino, Italy
| | - E Nuss
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - T Ohsugi
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - C Okada
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - N Omodei
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - E Orlando
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Denver, Colorado 80208, USA
| | - D Paneque
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Max-Planck-Institut für Physik, D-80805 München, Germany
| | - J S Perkins
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - M Pesce-Rollins
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - V Petrosian
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - F Piron
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - G Pivato
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - T A Porter
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - S Rainò
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - R Rando
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia "G. Galilei", Università di Padova, I-35131 Padova, Italy
| | - M Razzano
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
- Funded by contract FIRB-2012-RBFR12PM1F from the Italian Ministry of Education, University and Research (MIUR)
| | - S Razzaque
- Department of Physics, University of Johannesburg, PO Box 524, Auckland Park 2006, South Africa
| | - A Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - O Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - T Reposeur
- Centre d'Études Nucléaires de Bordeaux Gradignan, IN2P3/CNRS, Université Bordeaux 1, BP120, F-33175 Gradignan Cedex, France
| | - R W Romani
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M Sánchez-Conde
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
| | - J Schmid
- Laboratoire AIM, CEA-IRFU/CNRS/Université Paris Diderot, Service d'Astrophysique, CEA Saclay, F-91191 Gif sur Yvette, France
| | - A Schulz
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - C Sgrò
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - D Simone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
| | - E J Siskind
- NYCB Real-Time Computing Inc., Lattingtown, New York 11560-1025, USA
| | - F Spada
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - G Spandre
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - P Spinelli
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, I-70126 Bari, Italy
- Dipartimento di Fisica "M. Merlin" dell'Università e del Politecnico di Bari, I-70126 Bari, Italy
| | - D J Suson
- Department of Chemistry and Physics, Purdue University Calumet, Hammond, Indiana 46323-2094, USA
| | - H Takahashi
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - J B Thayer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - L Tibaldo
- Max-Planck-Institut für Kernphysik, D-69029 Heidelberg, Germany
| | - D F Torres
- Institute of Space Sciences (IEEC-CSIC), Campus UAB, E-08193 Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
| | - E Troja
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
| | - G Vianello
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M Yassine
- Laboratoire Univers et Particules de Montpellier, Université Montpellier, CNRS/IN2P3, Montpellier, France
| | - S Zimmer
- The Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
| |
Collapse
|
22
|
Nagata E, Nonaka T, Moriya Y, Fujii N, Okada Y, Tsukamoto H, Itoh J, Okada C, Satoh T, Arai T, Hasegawa M, Takizawa S. Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation. Mol Neurobiol 2015; 53:5377-83. [PMID: 26440668 DOI: 10.1007/s12035-015-9470-1] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2015] [Accepted: 09/30/2015] [Indexed: 12/30/2022]
Abstract
TAR DNA-binding protein 43 (TDP-43) has been identified as a major component of ubiquitin-positive inclusions in the brains and spinal cords of patients with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) or amyotrophic lateral sclerosis (ALS). The phosphorylated C-terminal fragment of TDP-43 forms aggregates in the neuronal cytoplasm, possibly resulting in neuronal cell death in patients with FTLD-U or ALS. The inositol pyrophosphate known as diphosphoinositol pentakisphosphate (InsP7) contains highly energetic pyrophosphate bonds. We previously reported that inositol hexakisphosphate kinase type 2 (InsP6K2), which converts inositol hexakisphosphate (InsP6) to InsP7, mediates cell death in mammalian cells. Moreover, InsP6K2 is translocated from the nucleus to the cytosol during apoptosis. In this study, we verified that phosphorylated TDP-43 co-localized and co-bound with InsP6K2 in the cytoplasm of anterior horn cells of the spinal cord. Furthermore, we verified that cell death was augmented in the presence of cytoplasmic TDP-43 aggregations and activated InsP6K2. However, cells with only cytoplasmic TDP-43 aggregation survived because Akt activity increased. In the presence of both TDP-43 aggregation and activated InsP6K2 in the cytoplasm of cells, the expression levels of HSP90 and casein kinase 2 decreased, as the activity of Akt decreased. These conditions may promote cell death. Thus, InsP6K2 could cause neuronal cell death in patients with FTLD-U or ALS. Moreover, InsP6K2 plays an important role in a novel cell death pathway present in FTLD-U and ALS.
Collapse
Affiliation(s)
- Eiichiro Nagata
- Department of Neurology, Tokai University School of Medicine, Isehara, Japan.
- , 143 Shimo-Kasuya, Isehara, Kanagawa, 259-1193, Japan.
| | - Takashi Nonaka
- Department of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
| | - Yusuke Moriya
- Department of Neurology, Tokai University School of Medicine, Isehara, Japan
| | - Natsuko Fujii
- Department of Neurology, Tokai University School of Medicine, Isehara, Japan
| | - Yoshinori Okada
- Support Center for Medical Research and Education, Tokai University, Isehara, Japan
| | - Hideo Tsukamoto
- Support Center for Medical Research and Education, Tokai University, Isehara, Japan
| | - Johbu Itoh
- Support Center for Medical Research and Education, Tokai University, Isehara, Japan
| | - Chisa Okada
- Support Center for Medical Research and Education, Tokai University, Isehara, Japan
| | - Tadayuki Satoh
- Support Center for Medical Research and Education, Tokai University, Isehara, Japan
| | - Tetsuaki Arai
- Department of Neuropsychiatry, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
| | - Masato Hasegawa
- Department of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
| | - Shunya Takizawa
- Department of Neurology, Tokai University School of Medicine, Isehara, Japan
| |
Collapse
|
23
|
Konno S, Hizawa N, Fukutomi Y, Taniguchi M, Kawagishi Y, Okada C, Tanimoto Y, Takahashi K, Akasawa A, Akiyama K, Nishimura M. The prevalence of rhinitis and its association with smoking and obesity in a nationwide survey of Japanese adults. Allergy 2012; 67:653-60. [PMID: 22335609 DOI: 10.1111/j.1398-9995.2012.02793.x] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/04/2012] [Indexed: 02/01/2023]
Abstract
BACKGROUND Rhinitis is a common disease, and its prevalence is increasing worldwide. Several studies have provided evidence of a strong association between asthma and rhinitis. Although smoking and obesity have been extensively analyzed as risk factors of asthma, associations with rhinitis are less clear. OBJECTIVE The aims of our study were (i) to evaluate the prevalence of rhinitis using the European Community Respiratory Health Survey (ECRHS) questionnaire in Japanese adults and (ii) to evaluate the associations of smoking and body mass index (BMI) with rhinitis. METHODS Following our study conducted in 2006-2007 to determine the prevalence of asthma using the ECRHS questionnaire, our present analysis evaluates the prevalence of rhinitis and its association with smoking and BMI in Japanese adults 20-79 years of age (N = 22819). We classified the subjects (20-44 or 45-79 years) into four groups as having (i) neither rhinitis nor asthma; (ii) rhinitis without asthma; (iii) asthma without rhinitis; or (iv) rhinitis with asthma. We then evaluated associations with smoking and BMI in each group. RESULTS The overall age-adjusted prevalence of rhinitis was 35.1% in men and 39.3% in women. A higher prevalence was observed in the younger population than in the older population. Active smoking and obesity were positively associated with asthma without rhinitis. In contrast, particularly in the 20- to 44-year age-group, active smoking and obesity were negatively associated with rhinitis without asthma. CONCLUSION The results of the present study suggest that smoking and obesity may have different effects on the development of rhinitis and asthma.
Collapse
Affiliation(s)
- S. Konno
- First Department of Medicine; School of Medicine; Hokkaido University; Hokkaido; Japan
| | - N. Hizawa
- Department of Pulmonary Medicine; Institute of Clinical Medicine; University of Tsukuba; Tsukuba; Japan
| | | | - M. Taniguchi
- Clinical Research Center for Allergy and Rheumatology; Sagamihara National Hospital; Kanagawa; Japan
| | - Y. Kawagishi
- Department of Internal Medicine; Kurobe City Hospital; Toyama; Japan
| | | | - Y. Tanimoto
- Department of Hematology, Oncology, Allergy and Respiratory Medicine; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama; Japan
| | - K. Takahashi
- National Hospital Organization; Minami-Okayama Medical Center; Okayama; Japan
| | - A. Akasawa
- Department of Allergy; Tokyo Metropolitan Children's Medical Center; Tokyo; Japan
| | - K. Akiyama
- Clinical Research Center for Allergy and Rheumatology; Sagamihara National Hospital; Kanagawa; Japan
| | - M. Nishimura
- First Department of Medicine; School of Medicine; Hokkaido University; Hokkaido; Japan
| |
Collapse
|
24
|
Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Takada Y, Okada C, Sakurai Y, Hosoya T, Kanai Y, Suzuki H, Shinomiya N. Identification of ABCG2 dysfunction as a major factor contributing to gout. Nucleosides Nucleotides Nucleic Acids 2012; 30:1098-104. [PMID: 22132963 DOI: 10.1080/15257770.2011.627902] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The ATP-binding cassette, subfamily G, member 2 gene ABCG2/BCRP locates in a gout-susceptibility locus (MIM 138900) on chromosome 4q. Recent genome-wide association studies also showed that the ABCG2 gene relates to serum uric acid levels and gout. Since ABCG2 is also known as a transporter of nucleotide analogs that are structurally similar to urate, and is an exporter that has common polymorphic reduced functionality variants, ABCG2 could be a urate secretion transporter and a gene causing gout. To find candidate mutations in ABCG2, we performed a mutation analysis of the ABCG2 gene in 90 Japanese patients with hyperuricemia and found six non-synonymous mutations. Among the variants, ATP-dependent urate transport was reduced or eliminated in five variants, and two out of the five variants (Q126X and Q141K) were frequently detected in patients. Haplotype frequency analysis revealed that there is no simultaneous presence of Q126X and Q141K in one haplotype. As Q126X and Q141K are a nonfunctional and half-functional haplotype, respectively, their genotype combinations are divided into four estimated functional groups. The association study with 161 male gout patients and 865 male controls showed that all of those who had dysfunctional ABCG2 had an increased risk of gout, and that a remarkable risk was observed in those with ≤1/4 function (OR, 25.8; 95% CI, 10.3-64.6; p = 3.39 × 10(-21)). In 2,150 Japanese individuals, the frequency of those with dysfunctional ABCG2 was more than 50%. Our function-based clinicogenetic analysis identified the combinations of dysfunctional variants of ABCG2 as a major contributing factor in Japanese patients with gout.
Collapse
Affiliation(s)
- H Matsuo
- Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Kanai M, Tokunaga T, Miyaji T, Mataki N, Okada C, Mitani K, Aono S, Kobari S, Hakozaki Y. Colonic varices as a result of persistent mesocolon of the ascending and descending colon. Endoscopy 2011; 43 Suppl 2 UCTN:E103-4. [PMID: 21424996 DOI: 10.1055/s-0030-1256137] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/10/2022]
Affiliation(s)
- M Kanai
- Department of Internal Medicine, Division of Gastroenterology, Japan Self Defense Force Central Hospital, Setagaya, Tokyo, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Spurgeon SEF, Chen AI, Ratterree B, Okada C, Palmbach G, Diaz K, Subbiah N, Capper C, Epner EE. Activity of vorinostat (SAHA), cladribine (2-CdA), and rituximab in previously untreated mantle cell lymphoma: A phase I/II study. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.8023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
27
|
Watanabe T, Okada T, Okada C, Onishi T, Watanabe H, Okamoto Y, Kitamura Y, Manabe S, Matsubara S, Kageji T, Iwai A. An aspergillotic aneurysm of the internal carotid artery following allogeneic bone marrow transplantation: successful management with catheter coil embolization and long-term antifungal agents. Transpl Infect Dis 2008; 11:49-53. [PMID: 18713137 DOI: 10.1111/j.1399-3062.2008.00336.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We report a case of a mycotic aneurysm of the internal carotid artery and cerebral hemorrhagic infarction resulting from Aspergillus middle ear infection in a patient with severe aplastic anemia who received unrelated bone marrow transplantation. Although a mycotic aneurysm is a rare complication, and most often fatal, the patient was successfully treated with catheter coil embolization of the internal carotid artery and long-term systemic antifungal therapy. This case emphasizes the need for the rapid diagnosis of potential fungal involvement of the vascular system and suggests the necessity for aggressive treatment, such as with the modality illustrated in this case.
Collapse
Affiliation(s)
- T Watanabe
- Department of Pediatrics, Tokushima University Hospital, Tokushima, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Duvic M, Vanaclocha F, Bernengo MG, Okada C, Breneman D, Zinzani PL, Zhang L, Bopp K, Laird G, Hirawat S, Prince M. Phase II study of oral panobinostat (LBH589), a potent pan-deacetylase inhibitor, in patients with refractory Cutaneous T-cell Lymphoma (CTCL). J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.8555] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
29
|
Aoshima H, Kimura A, Shibutani A, Okada C, Matsumiya Y, Kubo M. Evaluation of soil bacterial biomass using environmental DNA extracted by slow-stirring method. Appl Microbiol Biotechnol 2006; 71:875-80. [PMID: 16518623 DOI: 10.1007/s00253-005-0245-x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2005] [Revised: 10/25/2005] [Accepted: 11/01/2005] [Indexed: 10/25/2022]
Abstract
A simple and rapid method (slow-stirring method) for extracting environmental DNA (eDNA) from soils was constructed by physical mild stirring with chemical treatment. eDNA was extracted efficiently with minimal damage from various kinds of soil. The amount of eDNA and soil bacterial biomass showed a linear proportional relation [Y=(1.70x10(8))X, r2=0.96], indicating that bacterial biomass could be evaluated by quantifying levels of eDNA. Consequently, the average bacterial biomass in an agricultural field was calculated as 5.95x10(9) cells/g sample, approximately 10-100 times higher than that in non- and oil-polluted fields.
Collapse
Affiliation(s)
- H Aoshima
- Department of Bioscience and Technology, Faculty of Science and Engineering, Ritsumeikan University, Nojihigashi, Kusatsu, Shiga, 525-8577, Japan
| | | | | | | | | | | |
Collapse
|
30
|
Beaulieu JP, Bennett DP, Fouqué P, Williams A, Dominik M, Jørgensen UG, Kubas D, Cassan A, Coutures C, Greenhill J, Hill K, Menzies J, Sackett PD, Albrow M, Brillant S, Caldwell JAR, Calitz JJ, Cook KH, Corrales E, Desort M, Dieters S, Dominis D, Donatowicz J, Hoffman M, Kane S, Marquette JB, Martin R, Meintjes P, Pollard K, Sahu K, Vinter C, Wambsganss J, Woller K, Horne K, Steele I, Bramich DM, Burgdorf M, Snodgrass C, Bode M, Udalski A, Szymański MK, Kubiak M, Wieckowski T, Pietrzyński G, Soszyński I, Szewczyk O, Wyrzykowski L, Paczyński B, Abe F, Bond IA, Britton TR, Gilmore AC, Hearnshaw JB, Itow Y, Kamiya K, Kilmartin PM, Korpela AV, Masuda K, Matsubara Y, Motomura M, Muraki Y, Nakamura S, Okada C, Ohnishi K, Rattenbury NJ, Sako T, Sato S, Sasaki M, Sekiguchi T, Sullivan DJ, Tristram PJ, Yock PCM, Yoshioka T. Discovery of a cool planet of 5.5 Earth masses through gravitational microlensing. Nature 2006; 439:437-40. [PMID: 16437108 DOI: 10.1038/nature04441] [Citation(s) in RCA: 466] [Impact Index Per Article: 25.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2005] [Accepted: 11/14/2005] [Indexed: 11/08/2022]
Abstract
In the favoured core-accretion model of formation of planetary systems, solid planetesimals accumulate to build up planetary cores, which then accrete nebular gas if they are sufficiently massive. Around M-dwarf stars (the most common stars in our Galaxy), this model favours the formation of Earth-mass (M(o)) to Neptune-mass planets with orbital radii of 1 to 10 astronomical units (au), which is consistent with the small number of gas giant planets known to orbit M-dwarf host stars. More than 170 extrasolar planets have been discovered with a wide range of masses and orbital periods, but planets of Neptune's mass or less have not hitherto been detected at separations of more than 0.15 au from normal stars. Here we report the discovery of a 5.5(+5.5)(-2.7) M(o) planetary companion at a separation of 2.6+1.5-0.6 au from a 0.22+0.21-0.11 M(o) M-dwarf star, where M(o) refers to a solar mass. (We propose to name it OGLE-2005-BLG-390Lb, indicating a planetary mass companion to the lens star of the microlensing event.) The mass is lower than that of GJ876d (ref. 5), although the error bars overlap. Our detection suggests that such cool, sub-Neptune-mass planets may be more common than gas giant planets, as predicted by the core accretion theory.
Collapse
Affiliation(s)
- J-P Beaulieu
- PLANET/RoboNet Collaboration, CNRS, Université Pierre et Marie Curie UMR7095, 98bis Boulevard Arago, 75014 Paris, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Okada C, Horiba M, Matsumoto H, Torigoe R, Mizuuchi H, Murao M, Soda R, Takahashi K, Kimura G, Tanimoto Y. A study of clinical features of cough variant asthma. Int Arch Allergy Immunol 2002; 125 Suppl 1:51-4. [PMID: 11408774 DOI: 10.1159/000053854] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Patients with cough variant asthma (CVA) and classic asthma are frequently among subjects who present at clinics complaining of a chronic persistent cough. To reveal the features of CVA, we examined the differences in the clinical appearance between CVA and classic asthma. Ten CVA subjects and 11 classic asthmatics were enrolled in the study; they were recruited among patients who presented at the National Minamiokayama Hospital complaining of a chronic cough. The number of eosinophils in peripheral blood was 256 +/- 45.8/microl in CVA and 400 +/- 123/microl in classic asthma. Eosinophils represented 67% of the cells of sputum in CVA and 82% in classic asthma. Bronchial responsiveness to methacholine was Dmin 1.37 +/- 0.56 U in CVA and 0.71 +/- 0.46 U in classic asthma. There was no significant difference in these three parameters. There was only a significant difference in V25 between CVA and classic asthma, 80.0 +/- 6.9 and 52.2 +/- 10.0%, respectively. Eosinophil inflammation was almost the same in both CVA and classic asthma.
Collapse
Affiliation(s)
- C Okada
- Department of Allergy, National Minamiokayama Hospital, Okayama, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Kawai H, Kawahara S, Tada A, Kuyama A, Matsumoto H, Kimura G, Okada C, Soda R, Takahashi K, Okamoto S, Nakajima M. [Pulmonary involvement, pleural effusion, and electrocardiographic abnormality in hypereosinophilic syndrome]. Nihon Kokyuki Gakkai Zasshi 2001; 39:862-7. [PMID: 11855086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
A 47-year-old man was admitted to our hospital with complaints of cough and shortness of breath. Chest radiography showed infiltration of the right lung and left pleural effusion, the eosinophil count increased notably in the peripheral blood, sputum, and pleural effusion. Transbronchial lung biopsy revealed the invasion of eosinophils like eosinophilic pneumonia. Heart failure easily developed in this patient after the intravenous infusion. Myocardial involvement was suspected, and hypereosinophilic syndrome was diagnosed. After prednisolone was administered, the peripheral blood eosinophil count normalized rapidly, and subsequently, the pleural effusion and infiltration shadows in the lung disappeared.
Collapse
Affiliation(s)
- H Kawai
- Department of Internal Medicine, National Minami-Okayama Hospital
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Abstract
T cell lymphoproliferative disorders continue to be serious management problems, and so alternative therapeutic modalities are continuously being explored. One such strategy involves immunotherapy using the T cell receptor (TCR) as a target. Specifically we are attempting to develop a T cell receptor idiotype (TCR-Id) vaccine because the TCR-Id can serve as a tumor-specific antigen. In this article we will briefly review the rationale for TCR-Id vaccines, the preclinical models as developed in our laboratory, and a discussion of our current plans for a vaccine trial in mycosis fungoides.
Collapse
Affiliation(s)
- S A Reddy
- Stanford University Medical Center, California 94305, USA
| | | | | | | | | |
Collapse
|
34
|
Abstract
Environmental contamination by endocrine-disrupting chemicals (EDC) has been a major focus of recent research and policy discussions. EDC-suspected man-made chemicals used as raw materials or plasticizers have been shown to elute from plastic products. To examine whether the dialysate for continuous ambulatory peritoneal dialysis (CAPD) is contaminated with EDC, we determined bisphenol A (BPA), nonylphenol (NP), di-(2-ethylhexyl)phthalate (DEHP) and di-n-butyl phthalate (DBP) in the pre-used dialysate and in the peritoneal effluent from renal failure patients by gas chromatography/mass spectrometry. Concentrations of BPA, NP, DEHP and DBP were 0.02-0.23 ppb (microg/l), 0.09-0.22, 1.1-3.7, and <0.1-2.1 ppb, respectively, in the pre-used dialysate, and <0.01-0.07, <0.1-0.45, 0.35-1.23, and 0.42-1.76 ppb, respectively, in the effluent, from which the maximal daily contamination of BPA and NP by CAPD was estimated at the microgram level and that of phthalate esters at the 10-microg level. These concentrations are far less than the toxic dosage reported so far, so that CAPD is unlikely to contaminate patients seriously.
Collapse
Affiliation(s)
- K Sugimura
- Department of Urology, Osaka City University Medical School, Osaka, Japan.
| | | | | | | | | | | |
Collapse
|
35
|
Sakurai Y, Okada C. [Comparison by simulation of the efficiency of surgical blood order equation (SBOE) with that of maximum surgical blood order schedule (MSBOS)]. Masui 2001; 50:69-75. [PMID: 11211757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
The maximum surgical blood order schedule (MSBOS) is used to promote efficient blood ordering practice for surgical patients. A surgical order equation (SBOE) was developed to calculate the number of units of red blood cells that should be ordered considering specific patient variables. We compared the efficiency of SBOE with that of the MSBOS by simulations. A retrospective study compared the SBOE with the MSBOS for ordering red blood cells units (MAP) in patients for six types of operations at our hospital. The SBOE was calculated as follows: SBOE (units) = mean blood loss (g)/200 - (preoperative Hb - postoperative Hb) divided by (40/body weight (kg)). The SBOE reduced the ordered units more effectively than the MSBOS. The SBOE reduces crossmatch-to-transfusion ratio (C/T ratio) from 1.2 to 1.6 but it would reduce the ordered units in statistical significance in only two of six types of operations. In conclusion, the SBOE could improve C/T ratio.
Collapse
Affiliation(s)
- Y Sakurai
- Division of Anesthesiology, Chiba Rosai Hospital, Ichihara 290-0003
| | | |
Collapse
|
36
|
Horiba M, Kuyama A, Matsumoto H, Kawai H, Okada C, Tada A, Kawahara S, Soda R, Takahashi K. [Improvement of a case of broncholithiasis after spontaneous lithoptysis]. Nihon Kokyuki Gakkai Zasshi 2000; 38:914-7. [PMID: 11244727] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
A 53-year-old woman was admitted for recurrent hemoptysis and cough. The chest radiograph showed an infiltrative shadow in the left upper region. Chest tomogram and CT scan showed a small calcification and consolidation in the left upper lobe. Fiberoptic bronchoscopy revealed fresh hemorrhage from the left upper bronchus but no broncholith or bleeding point were detected. Since the symptoms had disappeared by 10 days after admission, the patient was discharged and followed up as an outpatient. Three weeks later, she spontaneously expectorated a stone 3 mm in maximum diameter, with an irregular surface. Analysis revealed that the stone's composition was 56% of calcium phosphate and 44% of calcium carbonate. Hemoptysis seemed to have been caused by the broncholith, which had originated as a calcification of a peribronchial lymph node that subsequently eroded its way into the airway. After lithoptysis, no recurrence has been observed.
Collapse
Affiliation(s)
- M Horiba
- Department Internal Medicine, National Minami-Okayama Hospital, 4066 Hayashima, Hayashima-cho, Tukubo-gun, Okayama, 701-0304, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Tada A, Kawahara S, Horita N, Horiba A, Tamaoki A, Okada C, Soda R, Takahashi K. [A case of elderly patient with pulmonary tuberculosis considered to be caused by exogenous reinfection]. Kekkaku 1999; 74:721-4. [PMID: 10565132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
A 84-year-old woman presented with chronic febrile illness and anorexia from June 1998. She was diagnosed as pulmonary tuberculosis and was admitted to our hospital in August 1998. Her sputum smear was Gaffky 2, and the type of chest radiograph was b III 3. By family contact examination in August 1998, chest radiological examinations of her husband, a 86-year-old man, showed consolidation in middle lobe, right pleural effusion and two calcified mediastinal lymphnodes. He was diagnosed as pulmonary tuberculosis complicated with pleurisy. He had poor controlled diabetes mellitus. Tubercle bacilli isolated from their sputa showed the same pattern in restriction fragment length polymorphism analysis. Pulmonary tuberculosis of the husband was considered to be caused by exogenous reinfection.
Collapse
Affiliation(s)
- A Tada
- Department of Internal Medicine, National Minami-Okayama Hospital, Japan
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Abstract
Serial changes in splenic volume of 25 patients (18 men and seven women; 53.4 +/- 20.8 years old, range 25-83) with acute pancreatitis who underwent CT examinations were retrospectively studied. Abdominal CT was performed within 3 days after the onset and there was at least one follow-up CT examination after this time. The percentage changes of splenic volume in the first (4-30 days) and second (31-100 days) follow-up CT were calculated. Splenic volume increased in the first follow-up CT (mean +/- SD: 197.8 +/- 121.0 cm3) compared with the initial CT (124.8 +/- 70.0; p < 0.0001), and then decreased in the second follow-up CT (179.7 +/- 100.7; p < 0.002). The average splenic volume increased 65.5 +/- 88.7% (range -10.4-377.4%) between the initial and first follow-up CT examinations. Five of 25 cases (20%) in whom size of spleen increased more than twice had severe acute pancreatitis (p < 0.05), complicated pseudocyst requiring surgical drainage (p < 0.05), pleural effusion (p < 0.01), splenic vein thrombosis or compression (p < 0.05) and longer hospital stay (p < 0.02) compared with patients with a smaller increase in splenic volume. In conclusion, transient splenomegaly was commonly seen in acute pancreatitis, especially in severe or complicated cases. Congestive splenomegaly caused by obstruction or stenosis of the splenic vein and non-specified acute splenitis were suspected of contributing to the transient splenomegaly.
Collapse
Affiliation(s)
- Y Tsushima
- Department of Radiology, National Defense Medical College, Saitama, Japan
| | | | | | | | | | | |
Collapse
|
39
|
Tada A, Kawahara S, Horita N, Horiba A, Tamaoki A, Okada C, Mishima Y, Soda R, Takahashi K. [Serum soluble interleukin-2 receptor in patients with pulmonary mycobacterial diseases]. Kekkaku 1999; 74:499-505. [PMID: 10423961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
Serum soluble interleukin-2 receptor (sIL-2R) levels were measured in patients with untreated pulmonary tuberculosis (24 cases), patients with multidrug-resistant intractable pulmonary tuberculosis (7 cases) and patients with pulmonary non-tuberculous mycobacteriosis (27 cases). Serum sIL-2R levels were elevated in patients with pulmonary mycobacterial diseases and were elevated in untreated pulmonary tuberculosis patients than in other patients. In patients with new tuberculosis, serum sIL-2R levels were higher in patients with extensive lesions. Serum sIL-2R level showed significant positive correlation with serum C-reactive protein level and erythrocyte sedimentation rate, and significant negative correlation with serum albumin level. In patients with intractable tuberculosis and patients with non-tuberculous mycobacteriosis, serum sIL-2R levels were lower than in patients with new tuberculosis. Even in patients with extensive lesions, serum sIL-2R levels were not elevated. Lower levels of serum sIL-2R, marker of immunocompetent cell activity, suggested that immunocompetent cell activity was suppressed in intractable tuberculosis and in non-tuberculous mycobacteriosis.
Collapse
Affiliation(s)
- A Tada
- Department of Internal Medicine, National Minami-Okayama Hospital, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Abstract
A beta2-microglobulin (beta2M) selective adsorbent (Lixelle) for direct hemoperfusion has been used for the treatment of hemodialysis patients with the long-term complication of dialysis related amyloidosis (DRA), but there is no significant correlation between the serum level of beta2M and the occurrence of DRA. Inflammatory cytokines such as interleukin (IL)-1, IL-6, and tumor necrosis factor alpha (TNFalpha) are related to the development of DRA. We studied the adsorptive rates of cytokines in vitro using the Lixelle adsorbent. The adsorptive rates were 98.5% for IL-1beta 98.0% for interleukin-1 receptor antagonist (IL-1RA), 82.9% for IL-6, 99.9% for IL-8, 31.2% for TNFalpha, and 46.1% for soluble TNF receptor (sTNFr), respectively. As the molecular weights of cytokines increase, the adsorptive rates decrease. The Lixelle column adsorbed beta2M and various inflammatory cytokines as well. Therefore, the removal of both beta2M and inflammatory cytokines may play an important role in the treatment of DRA.
Collapse
Affiliation(s)
- K Tsuchida
- Division of Artificial Kidney, Osaka City University Hospital, Osaka, Japan
| | | | | | | | | | | | | |
Collapse
|
41
|
da Silva Filho OG, Zinsly SDR, Okada C, Ferrari Júnior FM. Ectopic eruption of a mandibular lateral incisor. J Clin Pediatr Dent 1998; 21:177-85. [PMID: 9484125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
This article illustrates an unusual situation, the ectopic eruption of the mandibular permanent lateral incisor, through the case report of a patient with a Class I malocclusion at an early stage of the mixed dentition. The article is focused on the diagnosis of the ectopic eruption and advocates treatment with an active orthodontic therapy at the early stage of the mixed dentition, before the eruption of the permanent cuspid.
Collapse
Affiliation(s)
- O G da Silva Filho
- Hospital de Pesquisa e Reabilitacao de Lesoes Labio-Palatais, University of Sao Paulo, Bauru, Brazil
| | | | | | | |
Collapse
|
42
|
Ambrosio M, Antolini R, Auriemma G, Baker R, Baldini A, Barbarino GC, Barish BC, Battistoni G, Bellotti R, Bemporad C, Bernardini P, Bilokon H, Bisi V, Bloise C, Bosio T, Bower C, Bussino S, Cafagna F, Calicchio M, Campana D, Carboni M, Castellano M, Cecchini S, Cei F, Chiarella V, Corona A, Coutu S, De Cataldo G, Dekhissi H, De Marzo C, De Mitri I, De Vincenzi M, Di Credico A, Erriquez O, Fantini R, Favuzzi C, Forti C, Fusco P, Giacomelli G, Giannini G, Giglietto N, Goretti M, Grassi M, Grillo A, Guarino F, Guarnaccia P, Gustavino C, Habig A, Hanson K, Hawthorne A, Heinz R, Hong JT, Iarocci E, Katsavounidis E, Kearns E, Kyriazopoulou S, Lamanna E, Lane C, Levin DS, Lipari P, Longley NP, Longo MJ, Mancarella G, Mandrioli G, Margiotta-Neri A, Marini A, Martello D, Marzari-Chiesa A, Mazziotta MN, Michael DG, Mikheyev S, Miller L, Monacelli P, Montaruli T, Monteno M, Mufson S, Musser J, Nicoló D, Nolty R, Okada C, Orth C, Osteria G, Palamara O, Parlati S, Patera V, Patrizii L, Pazzi R, Peck CW, Petrera S, Pistilli P, Popa V, Rainó A, Reynoldson J, Ricciardi M, Ronga F, Rubizzo U, Sanzgiri A, Sartogo F, Satriano C, Satta L, Scapparone E, Scholberg K, Sciubba A, Serra-Lugaresi P, Severi M, Sitta M, Spinelli P, Spinetti M, Spurio M, Steinberg R, Stone JL, Sulak LR, Surdo A, Tarlé G, Togo V, Valente V, Walter CW, Webb R. High energy cosmic ray physics with underground muons in MACRO. II. Primary spectra and composition. Int J Clin Exp Med 1997. [DOI: 10.1103/physrevd.56.1418] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
43
|
Okada C. [Comparison of asthma score and peak flow rate (PEF) monitoring]. Nihon Rinsho 1996; 54:2939-43. [PMID: 8950934] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
We have now two markers, peak flow rate(PEF) and asthma score, which reflect symptoms of asthmatics. We estimated which marker reflect the change of symptom of asthma more rapidly or exactly. With using the point of 20% down from best PEF, we could get rapid information but not so exact one. But the point of 30% down brought more exact information but not rapid one. So, both PEF and asthma score are useful in monitoring the condition of asthmatics. Under reducing the amount of inhaled steroid, it seemed to be more useful to use monitoring of PEF than asthma score, because PEF showed the change one month before asthma score showed the attacks.
Collapse
Affiliation(s)
- C Okada
- National Sanatorium Minamiokayama Hospital
| |
Collapse
|
44
|
Soda R, Takahashi K, Tamaki A, Tanimoto Y, Okada C, Tada S, Ueda N, Shiota Y, Tamura N, Sato T. [Clinical study of bronchial asthma in adult, intractable asthmatics after introduction of guideline therapy]. Arerugi 1995; 44:1387-93. [PMID: 8871293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Introduction of Guideline for asthma treatment proposed by the committee of Japanese allergology have a tremendous impact on patients with bronchial asthma. Intractable asthmatics who have had to take some oral steroid to overcome disease severity, may have also some merit by this treatment, so that some of them might be no longer considered as intractable asthmatics. To clarify this, multicenter study was conducted. In this study, a case who have had more than 5 mg of prednisolone and/or 800 mu g of beclomethasone dipropionate throughout the year, was diagnosed as intractable asthmatics. In 845 case, 14.7%, 123 cases were diagnosed as intractable. These cases were significantly to be non-atopic and adult onset. Also, they have a significant tendency to be deteriorated by infection and careless drug administrations. Using the multiquantification method to examine the most powerful factor on intractable asthmatics, type of asthmatics was the most important and the past history of severe attack was the second. When intractable asthmatics diagnosed mainly by their BDP usage (BDP-intractable) were compared with intractable diagnosed by oral PSL (PSL-intractables), BDP-intractables were significantly atopic compared to PSL-intractables.
Collapse
Affiliation(s)
- R Soda
- National Sanatrium Minami Okayama Hosp
| | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Tsuruta H, Yamada H, Motoyashiki Y, Oka K, Okada C, Nakamura M. An automated ELISA system using a pipette tip as a solid phase and a pH-sensitive field effect transistor as a detector. J Immunol Methods 1995; 183:221-9. [PMID: 7541432 DOI: 10.1016/0022-1759(95)00058-i] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
A fully automated ELISA system was constructed using a pipette tip as a solid phase, urease as a detecting enzyme, and a pH-FET as a detector of urease activity. The inner wall of the end part of a pipette tip was used as a solid phase, and the urease activity of the conjugate, captured after a two-step immunoreaction, was measured by coupling the pipette tip with the pH-FET in a pH-measuring cell. Full automation of the ELISA system was achieved by using a disposable reagent cartridge and three pipetters for all mechanical operations, including sample dilution and B/F separation. This system can treat 60 samples per hour with an assay time of 21 min for all assay configurations. The system was applied to two-step sandwich assays for AFP, CEA, HBsAg, and HBsAb, a two-step competition assay for HBcAb, and a second antibody assay for HTLV-I Ab.
Collapse
Affiliation(s)
- H Tsuruta
- Central Research Laboratories, Kuraray Co. Ltd., Okayama, Japan
| | | | | | | | | | | |
Collapse
|
46
|
Matsushita I, Matsuno H, Kadowaki KM, Okada C, Tsuji H. Immunomodulating effects of the new anti-rheumatic drug tenidap on collagen-induced arthritis. Int J Immunopharmacol 1995; 17:213-9. [PMID: 7558516 DOI: 10.1016/0192-0561(95)00004-l] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
We investigated the in vivo action of the newly developed anti-rheumatic agent tenidap, CP-66,248 (Pfizer Inc., New York), on arthritis in collagen-induced arthritic mice. The inhibitory effect of tenidap on the development of arthritis was statistically more significant than piroxicam. The serum anti-type II collagen antibody titer was markedly inhibited in the mice treated by tenidap. These results suggest that, unlike NSAIDs, tenidap inhibits the progress of collagen-induced arthritis through its immunomodulating effect.
Collapse
Affiliation(s)
- I Matsushita
- Department of Orthopaedics and Rheumatology, Toyama Medical and Pharmaceutical University, Japan
| | | | | | | | | |
Collapse
|
47
|
Tada A, Kawahara S, Tamaoki A, Takeuchi M, Tanimoto Y, Okada C, Mishima Y, Soda R, Takahashi K, Kibata M. [Interferon production in peripheral blood cells of patients with pulmonary mycobacterial disease]. Nihon Kyobu Shikkan Gakkai Zasshi 1995; 33:114-119. [PMID: 7731113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Production of interferon (IFN)-alpha and IFN-gamma were examined in 31 patients with acute tuberculosis, 12 patients with atypical mycobacterial disease. IFN production was examined in cultures of unseparated fresh whole blood. Production of IFN-alpha was induced by hemagglutinating virus of Japan and production of IFN-gamma was induced by PHA. Patients with mycobacterial disease produced significantly less IFN-alpha than healthy subjects. In patients with acute tuberculosis, effective chemotherapy for 2 months restored IFN-alpha production. Patients produced less IFN-gamma than healthy subjects, but the difference was not significant. Patients with high serum CRP levels tended to produce little IFN-alpha. These results suggest that measurement of IFN production is useful for immunological evaluation of patients with mycobacterial disease.
Collapse
Affiliation(s)
- A Tada
- Department of Internal Medicine, National Sanatorium, Minami-Okayama Hospital, Okayama, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Sugiyama H, Eda R, Okada C, Hopp RJ, Bewtra AK, Townley RG. Eosinophil accumulation and activation in antigen-induced late asthmatic response in guinea pigs. J Asthma 1995; 32:37-45. [PMID: 7844087 DOI: 10.3109/02770909509089498] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
The purpose of this study was to investigate the participation of airway eosinophils in the antigen-induced late asthmatic response (LAR) and increased airway responsiveness in the guinea pig model of asthma. After antigen challenge, guinea pigs sensitized with aerosolized ovalbumin showed a late-phase decrease in specific airway conductance, which was accompanied by airway hyperresponsiveness to histamine, eosinophilia in the bronchoalveolar lavage fluid (BALF), decreased BALF eosinophil density, and increased generation of superoxide anions from purified BALF eosinophils. We demonstrated an association of the LAR with eosinophil accumulation and activation in the airway.
Collapse
Affiliation(s)
- H Sugiyama
- Allergic Disease Center, Creighton University School of Medicine, Omaha, Nebraska 68178
| | | | | | | | | | | |
Collapse
|
49
|
Kawahara S, Tada A, Takeuchi M, Kamisaka K, Okada C, Mishima Y, Soda R, Takahashi K, Kibata M, Nagare H. [Therapeutic potential of sparfloxacin for preventing mycobacterial infections]. Kekkaku 1994; 69:351-6. [PMID: 8007520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
We studied the therapeutic potential of utilizing sparfloxacin (SPFX), a newly developed quinolone, to prevent various mycobacterial infections. The in vitro activity of SPFX as a preventive agent for various mycobacteria was determined using the actual count method on Ogawa egg medium. The minimal inhibitory concentrations (MICs) of SPFX were as follows: ofloxacin-sensitive M. tuberculosis, 0.16-0.32 microgram/ml; ofloxacin-resistant M. tuberculosis, 0.63-2.5 micrograms/ml; M. avium; 0.63-10 micrograms/ml (MICs were equal or less than 1.25 micrograms/ml in seven out of 11 strains); M. intracellulare, 2.5-10 micrograms/ml (MICs were equal or more than 10 micrograms/ml in 17 out of 23 strains); M. kansasii, < or = 0.08-0.16 microgram/ml; M. fortuitum, < or = 0.08 microgram/ml; M. chelonae subsp. abscessus, > 10 micrograms/ml; M. chelonae subsp. chelonae, 0.63 microgram/ml; M. scrofulaceum, < or = 0.08 microgram/ml; M. nonchromogenicum, 1.25 micrograms/ml; M. xenopi, < or = 0.08 microgram/ml; M. gordonae, < or = 0.08 microgram/ml. The average serum concentrations of SPFX during the period of multiple oral administration (200 mg once a day) were 0.35 +/- 0.16 microgram/ml before administration, 0.67 +/- 0.32 microgram/ml after one hour, 1.13 +/- 0.21 microgram/ml after two hours, 1.27 +/- 0.32 microgram/ml after four hours and 1.31 +/- 0.34 micrograms/ml after six hours. These results indicate that SPFX has a strong therapeutic potential to prevent infections due to M. tuberculosis, M. kansasii, M. fortuitum, M. chelonae subsp. chelonae, M. scrofulaceum, M. xenopi and M. gordonae. Moreover, it may be expected to be a promising agent against infections due to ofloxacin-resistant M. tuberculosis, M. avium and M. nonchromogenicum.
Collapse
Affiliation(s)
- S Kawahara
- Department of Internal Medicine, National Sanatorium Minami Okayama Hospital, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Okada C, Eda R, Miyagawa H, Sugiyama H, Hopp RJ, Bewtra AK, Townley RG. Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro. Int Arch Allergy Immunol 1994; 103:384-90. [PMID: 8130652 DOI: 10.1159/000236658] [Citation(s) in RCA: 28] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
Cetirizine, a potent H1-antagonist, has been reported to inhibit eosinophil migration into human skin. We, therefore, further evaluated the effect of cetirizine on eosinophil function, including superoxide anion generation, chemotaxis, and eosinophil peroxidase (EP) release. In allergic subjects, superoxide anion generation 60 min after platelet-activating factor (PAF) activation was inhibited by concentrations of cetirizine ranging from 0.01 to 1 microgram/ml (2.612 x 10(-8) to 2.612 x 10(-6) M). No significant inhibition was observed in normal subjects. PAF (10(-6) M)-induced eosinophil chemotaxis was also inhibited by cetirizine. In allergic subjects, percent inhibitions were 47.5 +/- 6.1% at 0.01 microgram/ml, 50.8 +/- 5.1% at 0.1 microgram/ml and 58.9 +/- 6.4% at 1 microgram/ml of cetirizine. In allergic subjects, N-formyl-methionyl-lencyl-phenylalanine induced eosinophil chemotaxis was inhibited by cetirizine, although EP release was not. These results suggest cetirizine has effects on eosinophils which can not be explained by H1-blockade alone.
Collapse
Affiliation(s)
- C Okada
- Allergic Disease Center, Creighton University School of Medicine, Omaha, NB 68178
| | | | | | | | | | | | | |
Collapse
|